
<html lang="en"     class="pb-page"  data-request-id="fb621388-916c-4b2a-b64f-353ef7a91be1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm8009537;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2008.51.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Characterization of Thien-2-yl 1S,2R-Milnacipran Analogues as Potent Norepinephrine/Serotonin Transporter Inhibitors for the Treatment of Neuropathic Pain" /></meta><meta name="dc.Creator" content="Brian  Dyck" /></meta><meta name="dc.Creator" content="Junko  Tamiya" /></meta><meta name="dc.Creator" content="Florence  Jovic" /></meta><meta name="dc.Creator" content="Rebecca R.  Pick" /></meta><meta name="dc.Creator" content="Margaret J.  Bradbury" /></meta><meta name="dc.Creator" content="Julie  O’Brien" /></meta><meta name="dc.Creator" content="Jenny  Wen" /></meta><meta name="dc.Creator" content="Michael  Johns" /></meta><meta name="dc.Creator" content="Ajay  Madan" /></meta><meta name="dc.Creator" content="Beth A.  Fleck" /></meta><meta name="dc.Creator" content="Alan C.  Foster" /></meta><meta name="dc.Creator" content="Binfeng  Li" /></meta><meta name="dc.Creator" content="Mingzhu  Zhang" /></meta><meta name="dc.Creator" content="Joe A.  Tran" /></meta><meta name="dc.Creator" content="Troy  Vickers" /></meta><meta name="dc.Creator" content="Jonathan  Grey" /></meta><meta name="dc.Creator" content="John  Saunders" /></meta><meta name="dc.Creator" content="Chen  Chen" /></meta><meta name="dc.Description" content="Thien-2-yl 1S,2R-milnacipran analogues were synthesized and characterized as norepinephrine/serotonin transporter inhibitors. These compounds possessed higher potencies than 1S,2R-milnacipran (2R-1..." /></meta><meta name="Description" content="Thien-2-yl 1S,2R-milnacipran analogues were synthesized and characterized as norepinephrine/serotonin transporter inhibitors. These compounds possessed higher potencies than 1S,2R-milnacipran (2R-1..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 28, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8009537" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8009537" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8009537" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8009537" /></link>
        
    
    

<title>Characterization of Thien-2-yl 1S,2R-Milnacipran Analogues as Potent Norepinephrine/Serotonin Transporter Inhibitors for the Treatment of Neuropathic Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8009537" /></meta><meta property="og:title" content="Characterization of Thien-2-yl 1S,2R-Milnacipran Analogues as Potent Norepinephrine/Serotonin Transporter Inhibitors for the Treatment of Neuropathic Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0004.jpeg" /></meta><meta property="og:description" content=" Thien-2-yl 1S,2R-milnacipran analogues were synthesized and characterized as norepinephrine/serotonin transporter inhibitors. These compounds possessed higher potencies than 1S,2R-milnacipran (2R-1) while maintaining low molecular weight and moderate lipophilicity, which are the important features for the pharmacological and pharmacokinetic characteristics of milnacipran (1). Thus, compound 5c exhibited IC50 values of 2.3 and 32 nM, respectively, at NET and SERT, which were more than 10-fold better than those of 1 (NET IC50 = 77 nM, SERT IC50 = 420 nM). Moreover, 5c achieved the same efficacy as 1, but with much lower doses, in a rodent spinal nerve ligation pain model. In addition, 5c displayed desirable pharmacokinetic properties in several species, including high oral availability and significant brain penetration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8009537"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8009537">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8009537&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8009537&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8009537&amp;href=/doi/10.1021/jm8009537" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7265-7272</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800893q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800743q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Characterization of Thien-2-yl 1<i>S</i>,2<i>R</i>-Milnacipran Analogues as Potent Norepinephrine/Serotonin Transporter Inhibitors for the Treatment of Neuropathic Pain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Dyck">Brian Dyck</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junko++Tamiya">Junko Tamiya</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Jovic">Florence Jovic</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+R.++Pick">Rebecca R. Pick</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margaret+J.++Bradbury">Margaret J. Bradbury</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++O%E2%80%99Brien">Julie O’Brien</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Wen">Jenny Wen</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Johns">Michael Johns</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ajay++Madan">Ajay Madan</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beth+A.++Fleck">Beth A. Fleck</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+C.++Foster">Alan C. Foster</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Binfeng++Li">Binfeng Li</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mingzhu++Zhang">Mingzhu Zhang</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joe+A.++Tran">Joe A. Tran</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Troy++Vickers">Troy Vickers</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Grey">Jonathan Grey</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Saunders">John Saunders</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chen++Chen">Chen Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 858-617-7600. Fax: 858-617-7925. E-mail: <a href="/cdn-cgi/l/email-protection#7f1c1c171a113f111a0a0d101c0d16111a511c1012"><span class="__cf_email__" data-cfemail="2d4e4e4548436d4348585f424e5f444348034e4240">[email protected]</span></a></div><div class="corresp-fn" id="afn1">†Department of Medicinal Chemistry.</div><div class="corresp-fn" id="afn2">‡Department of Neuroscience.</div><div class="corresp-fn" id="afn3">§Department of Preclinical Development.</div><div class="corresp-fn" id="afn4">†Department of Pharmacology.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8009537&amp;href=/doi/10.1021%2Fjm8009537" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7265–7272</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 27, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 July 2008</li><li><span class="item_label"><b>Published</b> online</span>28 October 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 November 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8009537" title="DOI URL">https://doi.org/10.1021/jm8009537</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7265%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBrian%2BDyck%252C%2BJunko%2BTamiya%252C%2BFlorence%2BJovic%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D22%26contentID%3Djm8009537%26title%3DCharacterization%2Bof%2BThien-2-yl%2B1S%252C2R-Milnacipran%2BAnalogues%2Bas%2BPotent%2BNorepinephrine%252FSerotonin%2BTransporter%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BNeuropathic%2BPain%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7272%26publicationDate%3DNovember%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8009537"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1344</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8009537" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Characterization of Thien-2-yl 1S,2R-Milnacipran Analogues as Potent Norepinephrine/Serotonin Transporter Inhibitors for the Treatment of Neuropathic Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Dyck&quot;},{&quot;first_name&quot;:&quot;Junko&quot;,&quot;last_name&quot;:&quot;Tamiya&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Jovic&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;R. Pick&quot;},{&quot;first_name&quot;:&quot;Margaret&quot;,&quot;last_name&quot;:&quot;J. Bradbury&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;O’Brien&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Johns&quot;},{&quot;first_name&quot;:&quot;Ajay&quot;,&quot;last_name&quot;:&quot;Madan&quot;},{&quot;first_name&quot;:&quot;Beth&quot;,&quot;last_name&quot;:&quot;A. Fleck&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;C. Foster&quot;},{&quot;first_name&quot;:&quot;Binfeng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Mingzhu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Joe&quot;,&quot;last_name&quot;:&quot;A. Tran&quot;},{&quot;first_name&quot;:&quot;Troy&quot;,&quot;last_name&quot;:&quot;Vickers&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Grey&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Saunders&quot;},{&quot;first_name&quot;:&quot;Chen&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;7265-7272&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8009537&quot;},&quot;abstract&quot;:&quot;Thien-2-yl 1S,2R-milnacipran analogues were synthesized and characterized as norepinephrine/serotonin transporter inhibitors. These compounds possessed higher potencies than 1S,2R-milnacipran (2R-1) while maintaining low molecular weight and moderate lipophilicity, which are the important features for the pharmacological and pharmacokinetic characteristics of milnacipran (1). Thus, compound 5c exhibited IC50 values of 2.3 and 32 nM, respectively, at NET and SERT, which were more than 10-fold better than those of 1 (NET IC50 = 77 nM, SERT IC50 = 420 nM). Moreover, 5c achieved the same efficacy as 1, but with much lower doses, in a rodent spinal nerve ligation pain model. In addition, 5c displayed desirable pharmacokinetic properties in several species, including high oral availability and significant brain penetration.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8009537&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8009537" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8009537&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8009537" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8009537&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8009537" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8009537&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8009537&amp;href=/doi/10.1021/jm8009537" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8009537" /></input><a href="/doi/pdf/10.1021/jm8009537" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (237 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8009537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8009537%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DDyck%26date%3D2008%26atitle%3DCharacterization%2Bof%2BThien-2-yl%2B1S%252C2R-Milnacipran%2BAnalogues%2Bas%2BPotent%2BNorepinephrine%252FSerotonin%2BTransporter%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BNeuropathic%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D22%26spage%3D7265%26epage%3D7272%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Thien-2-yl 1<i>S</i>,2<i>R</i>-milnacipran analogues were synthesized and characterized as norepinephrine/serotonin transporter inhibitors. These compounds possessed higher potencies than 1<i>S</i>,2<i>R</i>-milnacipran (2<i>R</i>-<b>1</b>) while maintaining low molecular weight and moderate lipophilicity, which are the important features for the pharmacological and pharmacokinetic characteristics of milnacipran (<b>1</b>). Thus, compound <b>5c</b> exhibited IC<sub>50</sub> values of 2.3 and 32 nM, respectively, at NET and SERT, which were more than 10-fold better than those of <b>1</b> (NET IC<sub>50</sub> = 77 nM, SERT IC<sub>50</sub> = 420 nM). Moreover, <b>5c</b> achieved the same efficacy as <b>1</b>, but with much lower doses, in a rodent spinal nerve ligation pain model. In addition, <b>5c</b> displayed desirable pharmacokinetic properties in several species, including high oral availability and significant brain penetration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cell membrane monoamine transporters—norepinephrine (NET<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>), <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviation: NE, norepinephrine; SER, serotonin; DA, dopamine; NET, norepinephrine transporter; SERT, serotonin transporter; DAT, dopamine transporter; <i>r</i>NET, <i>r</i>SERT, and <i>r</i>DAT, rat synaptosomal transporters; sSRI, selective serotonin reuptake inhibitors; sNRI, selective norepinephrine reuptake inhibitors; NSRI, dual norepinephrine and serotonin reuptake inhibitor; CNS, central nerve system; log <i>P</i>, partition coefficient in log unit; log <i>D</i>, distribution coefficient in log unit; DCM, dichloromethane.</p></div> serotonin (SERT), and dopamine transporter (DAT)—are important targets for many CNS drugs.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Since the synaptic actions of monoamine neurotransmitters such as norepinephrine (NE) and serotonin (SER) are terminated by reuptake into the nerve terminals from which they are released or by uptake into adjacent cells, inhibition of this action prolongs the function of these monoamines. Both selective serotonin reuptake inhibitors (sSRI) and selective norepinephrine reuptake inhibitors (sNRI) are effective against major depression and a range of other psychiatric illnesses. On the other hand, the dopamine transporter (DAT) is a key target for amphetamine and methylphenidate, which are used in the treatment of attention deficit hyperactivity disorder (ADHD).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Many monoamine transporter inhibitors with various selectivity profiles have been used clinically for CNS-related diseases. For example, atomoxetine (<b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was introduced into the market as a sNRI for ADHD.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Recently, duloxetine (<b>7</b>), a dual NET/SERT inhibitor (NSRI), has been approved by the FDA for both depression and diabetic neuropathy.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> While the serotonin transporter inhibition is likely to improve depression,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> the norepinephrine reuptake blockade probably improves chronic pain.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Available as an antidepressant, milnacipran (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> inhibits norepinephrine and serotonin reuptake in a 3:1 ratio.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Compound <b>1</b> is currently in phase III clinical trials for fibromyalgia, and recent results showed its effectiveness in the treatment.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of milnacipran (<b>1</b>) and its analogues atomoxetine (<b>6</b>) and duloxetine (<b>7</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The moderately lipophilic <b>1</b> (log <i>D</i> ≈ 0) differs significantly from many CNS drugs such as <b>6</b>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Compound <b>1</b>, with a low molecular weight of 247, exhibits almost ideal pharmacokinetics in humans, including low intersubject variability and high oral bioavailability (∼85%).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> It has very low plasma protein binding (∼13%) and is mainly excreted in the urine as the parent and glucuronide (>80%). Only a small fraction (<10%) of <b>1</b> is metabolized via N-deethylation by the CYP3A4 enzyme.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This lack of potential for drug−drug interaction via cytochrome P450 enzymes is a quite attractive feature because many CNS drugs are highly lipophilic and rely heavily on liver enzymes for drug elimination.</div><div class="NLM_p">As a mixture of 1<i>S</i>,2<i>R</i>- and 1<i>R</i>,2<i>S</i>-isomers with a NET/SERT ratio of about 3:1, <b>1</b> is known to be a NET/SERT dual inhibitor.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, its potency at both NET and SERT is only moderate<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and mainly resides in the 1<i>S</i>,2<i>R</i>-isomer (2<i>R</i>-<b>1</b>).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> The structure−activity relationship (SAR) of <b>1</b> and its analogues based on in vivo efficacy was reported by Bonnaud and co-workers in 1987.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> We have recently described the SAR of a series of <i>N</i>-alkylamides and <i>N</i>,<i>N</i>-dialkylamides of <b>1</b> (NET IC<sub>50</sub> = 77 nM) and found that by replacing one of its ethyl groups with an allyl moiety resulted in an over 5-fold increase in NET potency (<b>2</b>, NET IC<sub>50</sub> = 14 nM).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Very recently, Roggen et al. reported the SAR studies of a series of analogues as single stereoisomers with various aromatic groups.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Their results show that the IC<sub>50</sub> values for the synaptosomal uptake inhibition of 1<i>S</i>,2<i>R</i>-milnacipran (2<i>R</i>-<b>1</b>, <i>r</i>NET IC<sub>50</sub> = 7 nM) is much lower than the 1<i>R</i>,2<i>S</i>-isomer (2<i>S</i>-<b>1</b>, <i>r</i>NET = 200 nM), and 2<i>R</i>-<b>1</b> is also about 3.5-fold more potent than 2<i>S</i>-<b>1</b> at <i>r</i>SERT.</div><div class="NLM_p last">Results from the SAR study by Roggen et al. on the substituted phenyl analogues of 2<i>R</i>-<b>1</b> show no improvement in potency, although substantial increases in both <i>r</i>NET and <i>r</i>SERT activities are observed when the phenyl ring of 2<i>S</i>-<b>1</b> is replaced by a more lipophilic 2-naphthyl group.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We have found that the NET activity of the single isomeric 3,4-ethylenedioxyphenyl <b>3a</b> (1<i>S</i>,2<i>R</i>, IC<sub>50</sub> = 6.3 nM) is 6-fold higher than 2<i>R</i>-<b>1</b> (IC<sub>50</sub> = 40 nM, <i>r</i>NET IC<sub>50</sub> = 16 nM).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The allyl analogue <b>3b</b> (1<i>S</i>,2<i>R</i>) has another 2-fold increase in both NET (IC<sub>50</sub> = 2.9 nM) and SERT (IC<sub>50</sub> = 65 nM). In comparison, the single isomeric thien-3-yl <b>4</b> (1<i>S</i>,2<i>R</i>) has a slight increase in SERT activity (IC<sub>50</sub> = 150 nM) compared to 2<i>R</i>-<b>1</b> (SERT IC<sub>50</sub> = 320 nM).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In our efforts to search potent NET-selective and NET/SERT dual inhibitors, we studied a series of thien-2-yl analogues of 2<i>R</i>-<b>1</b>. Here, we report the pharmacological and pharmacokinetic characterization of these compounds as NET and SERT inhibitors for the treatment of neuropathic pain.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The targeted compounds <b>5a</b>−<b>h</b> as 1<i>R</i>,2<i>R</i>-isomers were synthesized from 2-thienylacetonitrile <b>8</b> using the procedure shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The stereoselective cyclization to form the lactone <b>9</b> was modified to improve its ee value.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Thus, treatment of <b>8</b> with NaHMDS in THF at 0 °C followed by <i>R</i>-(−)-epichlorohydrin gave <b>9</b> (94% ee) after KOH hydrolysis. Ring opening of <b>9</b> with potassium phthalamide afforded the corresponding acid <b>10</b>. A small sample of the methyl ester <b>11</b> was obtained for X-ray crystal structure determination. Coupling reactions of <b>10</b> with several secondary amines gave the final products <b>5a</b>−<b>h</b> after deprotection with methylhydrazine.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0006.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) NaHMDS, THF, 0 °C; (ii) (<i>R</i>)-(−)-epichlorohydrin, 0 °C to room temp, 16 h; (iii) KOH, EtOH, reflux, 8 h; (iv) 12 N HCl, 0 °C to room temp, 2.5 h; (b) (i) potassium phthalamide, DMF, 120 °C, 16 h; (c) (COCl)<sub>2</sub>, MeOH, room temp, 2 h; (d) (i) SOCl<sub>2</sub>; (ii) R<sup>1</sup>R<sup>2</sup>NH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temp, 16 h; (iii) MeNHNH<sub>2</sub>, EtOH, room temp, 16 h.</p></p></figure><div class="NLM_p">The absolute stereochemistry (1<i>R</i>,2<i>R</i>) of these compounds, which matches that of 1<i>S</i>,2<i>R</i>-milnacipran 2<i>R</i>-<b>1</b> but with an opposite nomenclature due to the high priority of sulfur in the 2-thiophene, was confirmed by the X-ray structure of <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Pharmacology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The targeted compounds <b>5a</b>−<b>h</b> were tested in functional transporter assays evaluating their inhibition of cloned human NET, SERT, and DAT using a procedure similar to that described by Owens et al.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potencies of Compounds <b>5a</b>−<b>h</b> at the Human Monoamine Transporters (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0008.gif" alt="" id="gr5" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">IC<sub>50</sub>, nM</th><th align="center" valign="middle" char="."> </th></tr><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom">R<sup>1</sup>NR<sup>2</sup></th><th align="center" valign="bottom" char=".">NET</th><th align="center" valign="bottom" char=".">SERT</th><th align="center" valign="bottom" char=".">DAT</th><th align="center" valign="bottom" char=".">calcd log <i>P</i><a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b><a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></td><td align="left"> </td><td align="char" char=".">77</td><td align="char" char=".">420</td><td align="char" char=".">6100</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left">2<i>R</i>-<b>1</b></td><td align="left"> </td><td align="char" char=".">40</td><td align="char" char=".">320</td><td align="char" char=".">3200</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left"><b>5a</b></td><td align="left">EtNCH<sub>2</sub>CH═CH<sub>2</sub></td><td align="char" char=".">15</td><td align="char" char=".">140</td><td align="char" char=".">>10000</td><td align="char" char=".">1.2</td></tr><tr valign="top"><td align="left"><b>5b</b></td><td align="left">EtNCH<sub>2</sub>CF═CH<sub>2</sub></td><td align="char" char=".">4.4</td><td align="char" char=".">97</td><td align="char" char=".">>10000</td><td align="char" char=".">2.0</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="left">N(CH<sub>2</sub>CH═CH<sub>2</sub>)<sub>2</sub></td><td align="char" char=".">2.3</td><td align="char" char=".">32</td><td align="char" char=".">>10000</td><td align="char" char=".">1.7</td></tr><tr valign="top"><td align="left"><b>5d</b></td><td align="left">cPrNCH<sub>2</sub>CH═CH<sub>2</sub></td><td align="char" char=".">17</td><td align="char" char=".">45</td><td align="char" char=".">>10000</td><td align="char" char=".">1.1</td></tr><tr valign="top"><td align="left"><b>5e</b></td><td align="left">2-thiazoleCH<sub>2</sub>NCH<sub>2</sub>CH═CH<sub>2</sub></td><td align="char" char=".">13</td><td align="char" char=".">16</td><td align="char" char=".">>10000</td><td align="char" char=".">1.9</td></tr><tr valign="top"><td align="left"><b>5f</b></td><td align="left">EtNCH<sub>2</sub>C≡CH</td><td align="char" char=".">19</td><td align="char" char=".">81</td><td align="char" char=".">>10000</td><td align="char" char=".">0.8</td></tr><tr valign="top"><td align="left"><b>5g</b></td><td align="left">N(CH<sub>2</sub>C≡CH)<sub>2</sub></td><td align="char" char=".">6.0</td><td align="char" char=".">26</td><td align="char" char=".">>10000</td><td align="char" char=".">0.7</td></tr><tr valign="top"><td align="left"><b>5h</b></td><td align="left">1-isoindoline</td><td align="char" char=".">21</td><td align="char" char=".">13</td><td align="char" char=".">5539</td><td align="char" char=".">1.7</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left"> </td><td align="char" char=".">5.1</td><td align="char" char=".">190</td><td align="char" char=".">3100</td><td align="char" char=".">3.3</td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left"> </td><td align="char" char=".">8.9</td><td align="char" char=".">6.6</td><td align="char" char=".">660</td><td align="char" char=".">3.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Data are the average of two or more independent measurements.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Calculated using ACD software.</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">The following values at the cloned human transporters are reported by Neil Vaishnavi et al.: NET IC<sub>50</sub> = 68 nM, SERT IC<sub>50</sub> = 151 nM, DAT IC<sub>50</sub> > 100 000 nM; see ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>.</p></div></div></div><div class="NLM_p">The NET activity of the thien-2-yl compound <b>5a</b> was slightly lower than that of the thien-3-yl <b>4</b> (IC<sub>50</sub> = 5.6 nM). Incorporating a fluorine at the allyl group of <b>5a</b> improved its potency at NET (<b>5b</b>, NET IC<sub>50</sub> = 4.4 nM). Replacing the ethyl group of <b>5a</b> with an allyl moiety (<b>5c</b>) increased the NET and SERT activity by 5- to 6-fold. In comparison, the cyclopropyl analogue <b>5d</b> only improved SERT potency from <b>5a</b>. Similarly, the 2-thiazole <b>5e</b> showed improved SERT potency, resulting in a 1:1 ratio of NET/SERT inhibitory activity. The propargyl compounds <b>5f</b> and <b>5g</b> displayed similar profiles to the allyl analogues <b>5a</b> and <b>5c</b>, respectively. Finally, the isoindole <b>5h</b> exhibited potency and selectivity similar to the thiazole <b>5e</b> as a NET/SERT dual inhibitor, except <b>5h</b> showed a weak activity at DAT. As a reference, compound <b>6</b> had IC<sub>50</sub> values of 5.1 and 190 nM, respectively, at NET and SERT, while <b>7</b> had a 1:1 ratio at these transporters (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">At rat synaptosomes, <b>5c</b> showed about a 3-fold increase in both NET and SERT compared to 2<i>R</i>-<b>1</b>, while <b>5b</b> was less active (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of Compounds <b>1</b>, 2<i>R</i>-<b>1</b>, <b>4</b>, <b>5b</b>,<b>c</b>, <b>5f</b>, and <b>5h</b> at Rat Synaptosomes (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char="."><i>r</i>NET</th><th align="center" valign="middle" char="."><i>r</i>SERT</th><th align="center" valign="middle" char="."><i>r</i>DAT</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b><a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></td><td align="char" char=".">30</td><td align="char" char=".">47</td><td align="char" char=".">37000</td></tr><tr valign="top"><td align="left">2<i>R</i>-<b>1</b><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a></td><td align="char" char=".">16</td><td align="char" char=".">28</td><td align="char" char=".">20000</td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="char" char=".">6.4</td><td align="char" char=".">27</td><td align="char" char=".">>10000</td></tr><tr valign="top"><td align="left"><b>5b</b></td><td align="char" char=".">21</td><td align="char" char=".">160</td><td align="char" char=".">>10000</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="char" char=".">4.6</td><td align="char" char=".">11</td><td align="char" char=".">19000</td></tr><tr valign="top"><td align="left"><b>5f</b></td><td align="char" char=".">160</td><td align="char" char=".">160</td><td align="char" char=".">>10000</td></tr><tr valign="top"><td align="left"><b>5h</b></td><td align="char" char=".">15</td><td align="char" char=".">25</td><td align="char" char=".">2000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are the average of two independent measurements.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">The following values are reported by Mochizuki et al.: <i>r</i>NET IC<sub>50</sub> = 29.6 nM, <i>r</i>SERT IC<sub>50</sub> = 28 nM, <i>r</i>DAT IC<sub>50</sub> > 10 000 nM; see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">The following values are reported by Roggen et al.: <i>r</i>NET IC<sub>50</sub> = 7 nM, <i>r</i>SERT IC<sub>50</sub> = 120 nM, <i>r</i>DAT IC<sub>50</sub> = 10 000 nM; see ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>.</p></div></div></div><div class="NLM_p last">The selectivity of compounds <b>5b</b> and <b>5c</b> was tested at a concentration of 10 μM in a panel of radioligand binding assays for approximately 70 receptors, ion channels, enzymes and transporters; no significant activity was seen. This profile is quite similar to the high selectivity of milnacipran.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Metabolism and Pharmacokinetics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>5a</b>−<b>h</b> were profiled in an in vitro liver microsomal assay to assess their metabolic stability in comparison with <b>1</b> and <b>6</b>, and the results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Metabolic Profiles of 2-Thienyl Analogues <b>5a</b>−<b>h</b> in Comparison with <b>1</b> and <b>6</b></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">measured value<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th><th colspan="2" align="center" valign="middle" char=".">Cl<sub>sys</sub><a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a> (mL/(min·kg))</th><th colspan="2" align="center" valign="middle" char=".">Caco-2<a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a></th><th align="center" valign="middle"> </th></tr><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom" char=".">log <i>P</i></th><th align="center" valign="bottom">log <i>D</i></th><th align="center" valign="bottom" char=".">p<i>K</i><sub>a</sub></th><th align="center" valign="bottom" char=".">HLM</th><th align="center" valign="bottom">RLM</th><th align="center" valign="bottom" char="."><i>P</i><sub>app</sub>(nm/s)</th><th align="center" valign="bottom" char=".">efflux ratio</th><th align="center" valign="bottom">hERG<a class="ref internalNav" href="#tbl3-fn4" aria-label="d">d</a>IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="char" char=".">1.7</td><td align="left">0.2</td><td align="char" char=".">9.5</td><td align="char" char=".">3.1</td><td align="left">24</td><td align="char" char=".">89</td><td align="char" char=".">4.5</td><td align="left">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left">2<i>R</i>-<b>1</b></td><td align="char" char=".">1.6</td><td align="left">−0.2</td><td align="char" char=".">9.6</td><td align="char" char=".">5.0</td><td align="left">24</td><td align="char" char=".">51</td><td align="char" char=".">7.4<</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>5a</b></td><td align="char" char="."> </td><td align="left">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td><td align="char" char="."> </td><td align="char" char=".">11</td><td align="left">62</td><td align="char" char=".">137</td><td align="char" char=".">4.3</td><td align="left">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>5b</b></td><td align="char" char=".">1.8</td><td align="left">0.2</td><td align="char" char=".">9.4</td><td align="char" char=".">2.6</td><td align="left">54</td><td align="char" char=".">167</td><td align="char" char=".">3.2</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="char" char=".">2.0</td><td align="left">0.3</td><td align="char" char=".">9.4</td><td align="char" char=".">9.9</td><td align="left">61</td><td align="char" char=".">167</td><td align="char" char=".">3.8</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>5d</b></td><td align="char" char="."> </td><td align="left">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td><td align="char" char="."> </td><td align="char" char=".">5.0</td><td align="left">63</td><td align="char" char=".">178</td><td align="char" char=".">3.2</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>5e</b></td><td align="char" char=".">1.6</td><td align="left">−0.4</td><td align="char" char=".">9.4</td><td align="char" char=".">7.0</td><td align="left">47</td><td align="char" char=".">64</td><td align="char" char=".">14</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>5f</b></td><td align="char" char=".">1.6</td><td align="left">0.1</td><td align="char" char=".">9.4</td><td align="char" char=".">2.6</td><td align="left">44</td><td align="char" char=".">206</td><td align="char" char=".">4.2</td><td align="left">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>5g</b></td><td align="char" char=".">1.5</td><td align="left">0.2</td><td align="char" char=".">9.3</td><td align="char" char=".">2.6</td><td align="left">43</td><td align="char" char=".">250</td><td align="char" char=".">2.9</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>5h</b></td><td align="char" char=".">2.2</td><td align="left">0.5</td><td align="char" char=".">9.5</td><td align="char" char=".">8.8</td><td align="left">64</td><td align="char" char=".">84</td><td align="char" char=".">9.0</td><td align="left">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="char" char=".">3.5</td><td align="left">0.8</td><td align="char" char=".">10.1</td><td align="char" char=".">14.3</td><td align="left">ND<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a></td><td align="char" char=".">437</td><td align="char" char=".">1.0</td><td align="left">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Determined using pION’s Gemini Profiler.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Determined in vitro using liver microsomes; see <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for details. HLM: human liver microsomes. RLM: rat liver microsomes.</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">Digoxin was used as a control in the Caco-2 assay, and it showed on average <i>P</i><sub>app</sub> of 10 nm/s and efflux ratio of 20−30.</p></div><div class="footnote" id="tbl3-fn4"><sup>d</sup><p class="last">Determined using a patch-clamp assay; see <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for details.</p></div><div class="footnote" id="tbl3-fn5"><sup>e</sup><p class="last">ND: not determined.</p></div></div></div><div class="NLM_p">Compound <b>1</b> was quite stable metabolically in human liver microsomes (CL<sub>sys</sub> = 3.1 (mL/(min·kg)), supporting the low metabolic clearance of <b>1</b> observed in humans (nonrenal clearance = 273 mL/min).<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> The thien-2-yl analogue <b>5a</b> was less stable than 2<i>R</i>-<b>1</b>, as was the diallyl analogue <b>5c</b>, indicating that the C−C double bond might be a major site for oxidative metabolism. The metabolic stability of <b>5b</b> was, however, significantly increased from <b>5a</b> because of the addition of a fluorine to the allyl group. Incubation of <b>5c</b> with liver microsomes resulted in two detectable metabolites with molecular mass of +16 and +18, respectively, of the parent. Mass fragmentation studies indicated that the metabolism is at the amide side chain, suggesting that a reduction of the olefin bond followed by an oxidation could be a major metabolic pathway. Replacing the ethyl group of <b>5a</b> with cyclopropyl or thiazolemethyl resulted in analogues (<b>5d</b> and <b>5e</b>) with increased stability. Replacing the allyl group of <b>5a</b> and <b>5c</b> with a propargyl moiety significantly improved metabolic stability of these compounds (<b>5f</b> and <b>5g</b>). Finally, the lipophilic isoindoline (<b>5h</b>) showed only moderate stability in this assay; however, it was still better than the more lipophilic <b>6</b> (CL<sub>sys</sub> = 14.3 mL/(min·kg)). Compounds <b>5</b> possessed similar lipophilicity as <b>1</b> based on the measured log <i>P</i> or log <i>D</i> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">In a Caco-2 assay measuring cell permeability of these compounds, <b>5</b> displayed similar or slightly better profiles compared to 2<i>R</i>-<b>1</b>. Thus, 2<i>R</i>-<b>1</b> (log <i>D</i> = −0.2) had a <i>P</i><sub>app</sub> of 51 nm/s from apical to basolateral direction and an efflux ratio (basolateral to apical versus apical to basolateral direction) of 7.4. In comparison, the slightly more lipophilic <b>5b</b> (log <i>D</i> = 0.2) and <b>5c</b> (log <i>D</i> = 0.3) showed a <i>P</i><sub>aap</sub> of 167 nm/s and an efflux ratio of 3.2 and 3.8, respectively.</div><div class="NLM_p">None of the tested compounds showed significant inhibition (IC<sub>50</sub> > 10 μM) at hERG potassium channels, indicating a low potential for possible QT prolongation liability.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In contrast, <b>6</b> displayed an IC<sub>50</sub> of 2.1 μM in this assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compounds <b>5b</b> and <b>5c</b> had no significant inhibitory activity at the major cytochrome P450 enzymes (1A2, 2C9, 2C19, and 3A4) except CYP2D6 (IC<sub>50</sub> ≈ 6 μM), implying a low risk of potential drug−drug interactions via major liver enzymes.</div><div class="NLM_p">Compounds <b>5b</b>,<b>c</b>, <b>5f</b>, and <b>5h</b> were studied for their plasma and brain exposure after oral administration in comparison with 2<i>R</i>-<b>1</b> in Sprague−Dawley rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). On the basis of the in vitro rat liver microsomal studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), these compounds might be highly accessible to metabolic extraction when passing the liver in rats. Compound 2<i>R</i>-<b>1</b> had a <i>C</i><sub>max</sub> of 232 ng/mL and an area under the curve (AUC) of 566 ng/(mL·h) in plasma when dosed at 10 mg/kg to rats. Its brain concentrations measured at 1 and 4 h postdosing were 42% and 86% of those in plasma, indicating its fairly high brain penetration. Its apparent elimination half-life of 1.3 h was moderate in this species. The thien-2-yl compound <b>5b</b> or <b>5c</b> displayed a very similar profile to 2<i>R</i>-<b>1</b>, despite that they were much more metabolically labile based on the in vitro rat liver microsomal studies. The propargyl analogue <b>5f</b> had the highest AUC values, while the most lipophilic compound in this group, <b>5h</b>, had a very low <i>C</i><sub>max</sub> and AUC. As a reference, the following parameters were reported by Mattiuz et al. after an oral dose of 50 mg/kg <b>6</b> in Fischer 344 rats: <i>C</i><sub>max</sub> = 170 ng/mL, <i>T</i><sub>max</sub> = 2.0 h, AUC = 910 ng/(mL·h), apparent <i>t</i><sub>1/2</sub> = 2.8 h,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> indicating a high first pass effect in this species.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters of Compounds 2<i>R</i>-<b>1</b>, <b>5b</b>,<b>c</b>, <b>5f</b>, and <b>5h</b> in Sprague−Dawley Rats (<i>N</i> = 3) after Oral Administration (30 mg/kg)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">compd</th><th align="center" valign="bottom" char="."><i>C</i><sub>max</sub>(ng/mL)</th><th align="center" valign="bottom" char="."><i>T</i><sub>max</sub> (h)</th><th align="center" valign="bottom" char=".">AUC (ng/(mL·h))</th><th align="center" valign="bottom" char=".">apparent <i>t</i><sub>1/2</sub> (h)</th><th align="center" valign="bottom" char=".">CL/F (mL/(min·kg))</th><th align="center" valign="bottom"><i>C</i><sub>brain</sub>(ng/g) at 1, 4 h</th><th align="center" valign="bottom">b/p ratio at 1, 4 h</th></tr></thead><tbody><tr valign="top"><td align="left">2<i>R</i>-<b>1</b><a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></td><td align="char" char=".">232</td><td align="char" char=".">0.3</td><td align="char" char=".">566</td><td align="char" char=".">1.3</td><td align="char" char=".">294</td><td align="left">103, 5</td><td align="left">0.42, 0.86</td></tr><tr valign="top"><td align="left"><b>5b</b></td><td align="char" char=".">974</td><td align="char" char=".">0.4</td><td align="char" char=".">1498</td><td align="char" char=".">0.9</td><td align="char" char=".">334</td><td align="left">70, 31</td><td align="left">0.73, 1.1</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="char" char=".">522</td><td align="char" char=".">0.5</td><td align="char" char=".">1126</td><td align="char" char=".">1.2</td><td align="char" char=".">444</td><td align="left">127, 26</td><td align="left">0.6, 1.4</td></tr><tr valign="top"><td align="left"><b>5f</b></td><td align="char" char=".">649</td><td align="char" char=".">1.7</td><td align="char" char=".">3208</td><td align="char" char=".">1.9</td><td align="char" char=".">156</td><td align="left">230, 112</td><td align="left">0.3, 0.3</td></tr><tr valign="top"><td align="left"><b>5h</b></td><td align="char" char=".">58</td><td align="char" char=".">1.1</td><td align="char" char=".">272</td><td align="char" char=".">2.3</td><td align="char" char=".">1838</td><td align="left">28, 24</td><td align="left">1.0, 1.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Dosed at 10 mg/kg.</p></div></div></div><div class="NLM_p">The pharmacokinetic parameters of <b>5b</b> and <b>5c</b> were determined after intravenous administration to Sprague−Dawley rats to compare with those of 2<i>R</i>-<b>1</b>, and the results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. 2<i>R</i>-<b>1</b> had a high plasma clearance and a volume of distribution (<i>V</i><sub>d</sub>) of 4.3 L/kg, resulting in a short half-life (<i>t</i><sub>1/2</sub> = 0.8 h). Its oral bioavailability (<i>F</i> = 16%) was low. In comparison, compound <b>5b</b> had a very high plasma clearance (CL<sub>p</sub> = 140 mL/(min·kg)). Despite its high <i>V</i><sub>d</sub> of 7.5 L/kg, <b>5b</b> had a short half-life (<i>t</i><sub>1/2</sub> = 0.6 h) in this species. Part of the high plasma clearance of <b>5b</b> was attributed by its high renal clearance (CL<sub>r</sub> = 59 mL/(min·kg)), since over 30% of <b>5b</b> was excreted to the urea as unchanged parent. In contrast, compound <b>5c</b> had a lower renal clearance (CL<sub>r</sub> = 11 mL/(min·kg)). As a reference, <b>6</b> has a moderate plasma clearance (CL<sub>p</sub> = 36.4 mL/(min·kg)) but a very low oral bioavailability (1.5%).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It is worth nothing that <b>6</b> is not detectable in the urine.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of 2<i>R</i>-<b>1</b> and <b>5b</b>,<b>c</b> in Sprague−Dawley Rats (<i>N</i> = 3) after iv Adminisration (5 mg/kg)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char=".">AUC (ng/(mL·h))</th><th align="center" valign="middle" char="."><i>t</i><sub>1/2</sub>(h)</th><th align="center" valign="middle" char=".">MRT (h)</th><th align="center" valign="middle" char=".">CL<sub>p</sub>(mL/(min·kg))</th><th align="center" valign="middle">CL<sub>r</sub>(ml/(min·kg))</th><th align="center" valign="middle" char=".">Vd<sub>ss</sub>(L/kg)</th><th align="center" valign="middle" char=".">Vd (L/kg)</th><th align="center" valign="middle" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top"><td align="left">2<i>R</i>-<b>1</b><a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></td><td align="char" char=".">897</td><td align="char" char=".">0.8</td><td align="char" char=".">0.52</td><td align="char" char=".">58</td><td align="left">nd</td><td align="char" char=".">2.0</td><td align="char" char=".">4.3</td><td align="char" char=".">16.0</td></tr><tr valign="top"><td align="left"><b>5b</b></td><td align="char" char=".">532</td><td align="char" char=".">0.6</td><td align="char" char=".">0.7</td><td align="char" char=".">140</td><td align="left">59</td><td align="char" char=".">5.5</td><td align="char" char=".">7.5</td><td align="char" char=".">47.0</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="char" char=".">721</td><td align="char" char=".">0.6</td><td align="char" char=".">0.7</td><td align="char" char=".">102</td><td align="left">11</td><td align="char" char=".">4.4</td><td align="char" char=".">5.3</td><td align="char" char=".">12.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Dosed at 2.5 mg/kg.</p></div></div></div><div class="NLM_p">The plasma protein binding of <b>1</b> in rats is unknown but expected to be low based on the human data (13%) and low lipophilicity (log <i>D</i> = 0.2). The volume of distribution at steady state of 2<i>R</i>-<b>1</b> (<i>V</i><sub>ss</sub> = 2.0 L/kg) was not significantly lower than that of <b>6</b> (<i>V</i><sub>ss</sub> = 4.4 L/kg),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In contrast, the lipophilic <b>6</b> is reported to have a plasma protein binding of 89% in rats.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Compounds <b>5b</b> and <b>5c</b> were also profiled in other species for their PK properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compound <b>5b</b> had high oral bioavailability in both monkeys and beagle dogs, which were better than <b>5c</b>, although <b>5c</b> had high oral bioavailability in mice. Oral bioavailability of <b>5c</b> was comparable to <b>6</b> (73%) in dogs.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Properties of <b>5b</b> and <b>5c</b> in Mice, Monkeys, and Dogs<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">species</th><th align="center" valign="middle" char=".">CL<sub>p</sub> (mL/(min·kg))</th><th align="center" valign="middle">CL<sub>r</sub> (mL/(min·kg)</th><th align="center" valign="middle" char=".">t<sub>1/2</sub> (h)</th><th align="center" valign="middle" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th align="center" valign="middle" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th align="center" valign="middle" char="."><i>T</i><sub>max</sub> (h)</th><th align="center" valign="middle" char=".">AUC (ng/mL·h)</th><th align="center" valign="middle" char="."><i>F</i></th></tr></thead><tbody><tr valign="top"><td align="left"><b>5b</b></td><td align="left">Monkey</td><td align="char" char=".">34</td><td align="left">6</td><td align="char" char=".">4.3</td><td align="char" char=".">4.4</td><td align="char" char=".">2440</td><td align="char" char=".">2.3</td><td align="char" char=".">9050</td><td align="char" char=".">70</td></tr><tr valign="top"><td align="left"> </td><td align="left">Dog</td><td align="char" char=".">10.8</td><td align="left">2.2</td><td align="char" char=".">3.5</td><td align="char" char=".">2.4</td><td align="char" char=".">5570</td><td align="char" char=".">1.2</td><td align="char" char=".">47500</td><td align="char" char=".">109</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="left">Mouse</td><td align="char" char=".">135</td><td align="left">ND<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></td><td align="char" char=".">0.79</td><td align="char" char=".">5.4</td><td align="char" char=".">1731</td><td align="char" char=".">0.3</td><td align="char" char=".">3020</td><td align="char" char=".">92</td></tr><tr valign="top"><td align="left"> </td><td align="left">Monkey</td><td align="char" char=".">22.9</td><td align="left">3.9</td><td align="char" char=".">2.1</td><td align="char" char=".">3.8</td><td align="char" char=".">905</td><td align="char" char=".">4.5</td><td align="char" char=".">6316</td><td align="char" char=".">34</td></tr><tr valign="top"><td align="left"> </td><td align="left">Dog</td><td align="char" char=".">19.2</td><td align="left">2</td><td align="char" char=".">2.4</td><td align="char" char=".">3.6</td><td align="char" char=".">2546</td><td align="char" char=".">1.8</td><td align="char" char=".">17059</td><td align="char" char=".">78</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Data obtained following the administration of a single intravenous bolus (5 mg/kg) or an oral gavage (30 mg/kg) dose of compounds <b>5b</b> or <b>5c</b> as a hydrochloride salt.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">ND: not determined.</p></div></div></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">In Vivo Efficacy in Pain Models</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previous studies have shown that both NE and SER may contribute to antinociception: NE in supraspinal descending pathway and SER in spinal pathway.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> Furthermore, multiple studies have also suggested that the action of NE and SER in these pathways may produce synergistic effects.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> To examine the contribution of SER and NE to antinociception, the present series of compounds were used to examine the relative contributions of NE and SER to antinociception in a model of persistent pain.</div><div class="NLM_p">Compounds <b>4</b>, <b>5b</b>, <b>5c</b>, <b>5f</b>, and <b>5h</b> were studied in a rat formalin test to compare with 2<i>R</i>-<b>1</b>. Oral administration of these compounds at 60 mg/kg reduced the number of hindpaw flinches as much as 56% compared to vehicles (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Compounds <b>5b</b>, <b>5c</b>, and <b>5f</b> showed significant better efficacy than 2<i>R</i>-<b>1</b>, while <b>5h</b> did not display an effect.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds 2<i>R</i>-<b>1</b>, <b>4</b>, <b>5b</b>,<b>5c</b>, <b>5f</b>, and <b>5h</b> in rat formalin test (phase IIA) after 60 mg/kg oral administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>5c</b> was further studied with dose response in comparison with 2<i>R</i>-<b>1</b>, and the results are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. 2<i>R</i>-<b>1</b> demonstrated statistical significance in reduction of the number of hindpaw flinches only at 100 mg/kg. In comparison, at a dose of 30 mg/kg, <b>5c</b> showed the same effect as the 100 mg/kg of 2<i>R</i>-<b>1</b>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose−response of compound <b>5c</b> in rat formalin test (phase IIA) in comparison with 2<i>R</i>-<b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Acutely administrated <b>5c</b> (3, 10, and 30 mg/kg, po) dose-dependently reversed mechanical hyperalgesia induced by pin-prick in spinal nerve ligation (SNL) rats (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The highest dose (30 mg/kg) of <b>5c</b> produced about a 60% reversal. In comparison, 2<i>R</i>-<b>1</b> also produced a dose-dependent reversal but with much higher doses (60 and 100 mg/kg, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose-dependent reversal of pin-prick-induced mechanical hyperalgesia by compounds <b>5c</b> and 2<i>R</i>-<b>1</b> in rat SNL model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of thien-2-yl 1<i>S</i>,2<i>R</i>-milnacipran analogues were synthesized and studied as norepinephrine/serotonin transporter inhibitors. These compounds showed higher potencies than milnacipran at NET and SERT. Compounds <b>5b</b> and <b>5c</b> showed high oral bioavailability in several species. In addition, compound <b>5c</b> demonstrated efficacy in persistent and neuropathic pain models. Therefore, compounds such as <b>5c</b> will have the potential for the clinical treatment of neuropathic pain.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84766" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84766" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Methods</h4><div class="NLM_p last">NMR spectra were recorded on a Varian 300 MHz spectrometer with TMS as an internal standard. <sup>13</sup>C NMR spectra were recorded at 75 MHz. Chemical shifts are reported in parts per million (δ), and signals are expressed as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or br (broad). Purity measurements were performed on an HP Agilent 1100 HPLC−MS (detection at 220 and 254 nm). Chiral purity analyses were performed on a Chiralpak AD-H ADHOCE-KD016 column, with a mobile phase of 10% isopropanol/90% hexane + 0.1% diethylamine at 1 mL/min flow rate.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Typical Procedure: Synthesis of <i>N</i>,<i>N</i>-Diallyl (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarbamide Hydrochloride (<b>5c</b>)</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>Z</i>)-1<i>R</i>-(2-Thienyl)-3-oxa-bicyclo[3,1,0]hexan-2-one (<b>9</b>)</h4><div class="NLM_p last">To a stirred solution of NaHMDS (1 M in THF, 9.581 L) was added dropwise 2-thienylacetonitrile (<b>8</b>, 536 g, 4.351 mol) in THF (2.1 L) at 0 °C over 2 h under nitrogen atmosphere. After additional 30 min of stirring, <i>R</i>-(−)-epichlorohydrin (97% ee, 400.93 g, 4.351 mol) in THF (2.4 L) was added dropwise (3 h) while maintaining a reaction temperature below 8 °C. The mixture was stirred for 2 h at 0 °C and then allowed to warm to room temperature overnight. Aqueous KOH (1M, 13.4 mL) and EtOH (26.8 mL) were added to the reaction mixture, and solvent volume was reduced under vacuum to approximately 3 L. Aqueous KOH (1 M, 415 mL) and EtOH (1.072 L) were added, and the mixture was refluxed under nitrogen atmosphere for 8 h and then stirred at room temperature for 13 h. The reaction mixture was placed in an ice bath, and hydrochloric acid (12 M) was added dropwise (2 h) under a stream of nitrogen until the pH was 1. The mixture was stirred for 2 h at 0 °C and then allowed to warm to room temperature. The material was extracted (ethyl acetate 2 L × 1, DCM 1.5 L × 3), and the combined organic fractions were concentrated under reduce pressure. The resulting tar residue was dissolved in ethyl acetate (2 L) and washed twice with aqueous sodium bicarbonate (1.5 L). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a thick brown oil (578 g), which was purified by chromatography using hexanes and ethyl acetate to afford the title compound (410 g, 52%) as a brown oil. HPLC: 94% ee. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 1.48 (t, <i>J</i> = 5.8 Hz, 1H), 1.71 (dd, <i>J</i> = 5.8, 7.5 Hz, 1H), 2.61 (m, 1H), 4.28 (d, <i>J</i> = 9.3 Ha, 1H), 4.48 (dd, <i>J</i> = 4.5, 9.3 Hz, 1H), 6.98 (dd, <i>J</i> = 3.9, 5.1 Hz), 7.07 (dd, <i>J</i> = 0.9, 3.6 Hz, 1H), 7.23 (dd, <i>J</i> = 1.2, 5.1 Hz, 1H).</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (1<i>R</i>,2<i>R</i>)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-ylmethyl)-1-(2-thienyl)cyclopropanecarboxylic Acid (<b>10</b>)</h4><div class="NLM_p last">A mixture of (<i>Z</i>)-1<i>R</i>-(2-thienyl)-3-oxabicyclo[3,1,0]hexan-2-one (<b>9</b>, 118 g, 0.655 mmol) and potassium phthalimide (122 g, 0.655 mmol) in DMF (500 mL) was heated at 145 °C in a sealed vessel overnight. The mixture was cooled to room temperature, poured over 5 L of cold water, which was washed with ethyl acetate (2 L × 3), acidified at 0 °C with hydrochloric acid (1 M), and extracted with ethyl acetate (2 L, then 1 L). The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give the crude product, which was purified by chromatography using hexanes and ethyl acetate to afford the title compound (66 g, 31%) as a light-brown oil. HPLC: 96.5% ee. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 1.61 (dd, <i>J</i> = 4.8, 9.3 Hz, 1H), 2.00 (dd, <i>J</i> = 4.8, 7.5 Hz, 1H), 2.16 (m, 1H), 4.11 (d, <i>J</i> = 6.6 Hz, 2H), 6.88 (dd, <i>J</i> = 3.6, 5.1 Hz, 1H), 6.94 (dd, <i>J</i> = 1.5, 3.6 Hz, 1H), 7.17 (dd, <i>J</i> = 1.5, 5.4 Hz, 1H), 7.72 (dd, <i>J</i> = 3.3, 5.7 Hz, 2H), 7.86 (dd, <i>J</i> = 2.7, 5.4 Hz, 2H). MS: 328 (MH<sup>+</sup>).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Methyl (1<i>R</i>,2<i>R</i>)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-ylmethyl)-1-(2-thienyl)cyclopropanecarboxylate (<b>11</b>)</h4><div class="NLM_p">(1<i>R</i>,2<i>R</i>)-2-(1,3-Dioxo-1,3-dihydroisoindol-2-ylmethyl)-1-(2-thienyl)cyclopropanecarboxylic acid (<b>10</b>, 7.90 g, 24 mmol) and DMF (0.25 mL) were combined in DCM (100 mL) and cooled in an ice bath. Oxalyl chloride in DCM (2.0 M, 30 mL, 60 mmol) was added over 5 min, the ice bath was removed, and the resulting mixture was stirred at room temperature for 3 h. The mixture was concentrated in vacuo to afford the crude acid chloride (8.41 g, 100%), which was used without further purification.</div><div class="NLM_p last">A portion of the above material (2.21 g, 6.4 mmol) was quenched slowly with methanol (10 mL). After 10 min, ethyl acetate (100 mL) was added and the mixture was left standing for several days. After the slow evaporation of approximately half of the reaction volume, large brown rhomboid crystals formed which were isolated by filtration. One of the crystals was retained for X-ray analysis, and the remainder were crushed to afford the titled compound (1.82 g, 83%) as a tan solid: <sup>1</sup>H NMR (CDCl<sub>3</sub>): 1.53 (dd, <i>J</i> = 9.0, 4.8 Hz, 1 H), 1.94 (dd, <i>J</i> = 7.5, 4.8 Hz, 1 H), 2.14−2.04 (m, 1 H), 3.78 (s, 3 H), 4.09−3.96 (m, 2 H), 6.88−6.84 (m, 2 H), 7.16−7.13 (m, 1 H), 7.76−7.69 (m, 2 H), 7.90−7.83 (m, 2 H). MS: 342.0 (MH<sup>+</sup>).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>,<i>N</i>-Diallyl (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide Hydrochloride (<b>5c</b>)</h4><div class="NLM_p">Thionyl chloride (52.16 g, 0.438 mol) in DCM (90 mL) was added dropwise, over 15 min, to a stirred solution of (1<i>R</i>,2<i>R</i>)-2-(1,3-dioxo-1,3-dihydroisoindol-2-ylmethyl)-1-(2-thienyl)cyclopropanecarboxylic acid (10, 15 g, 0.046 mol) in DCM (150 mL) under a nitrogen atmosphere at room temperature. After 3 h, the mixture was concentrated in vacuo. The resulting residual was dissolved in DCM (200 mL) and cooled to 0 °C under a nitrogen atmosphere. To this stirred solution was added diallylamine (17.6 mL, 0.24 mol) in DCM (50 mL) dropwise over 30 min, then triethylamine (15 mL, 0.21 mol) in DCM (50 mL) dropwise over 30 min. The mixture was stirred at 0 °C for 1 h and then at room temperature for 2 h, washed with concentrated aqueous ammonium chloride (3 × 100 mL) and brine (2 × 50 mL), dried over sodium sulfate, filtered, and concentrated in vacuo to give a red oil (15.58 g) that partially solidified after 12 h. This material was triturated in 5:1 EtOH/EtOAc to give an off-white solid (6.44 g). The solid was chromatographed on silica gel (20% ethyl acetate in hexanes) to afford <i>N</i>,<i>N</i>-diallyl (1<i>R</i>,2<i>R</i>)-2-(1,3-dioxo-1,3-dihydroisoindol-2-ylmethyl)-1-(2-thienyl)-cyclopropanecarboxamide (6.16 g, 32%) as a white solid.</div><div class="NLM_p last">The above compound (4.98 g, 12.0 mmol) was dissolved in a mixture of toluene (100 mL) and ethanol (15 mL) and purged with nitrogen (3 min). To the stirred mixture under a stream of nitrogen was added methylhydrazine (10 mL) slowly. The clear yellow mixture was purged with nitrogen (1 min), and the reaction vessel was sealed and stirred for 17 h. The white precipitate (2.24 g) was removed by vacuum filtration and rinsed with toluene/ethanol (10:1). The filtrate was concentrated in vacuo to give a clear amber oil (5.75 g) which was purified to afford <i>N</i>,<i>N</i>-diallyl (1<i>R</i>,2<i>R</i>)-2-(aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide (2.34 g) as a yellowish oil, which was dissolved in DCM (90 mL) and treated with HCl (2 M in diethylether) until the solution was slightly acific based on dampened pH paper. The solution was concentrated in vacuo to afford the title compound (1.98 g, 51%) as a white solid. Mp = 148.6 °C (crystallized from isopropanol−ethyl acetate−diethyl ether). HPLC purity: 100% (220 nm) and 99.3% (254 nm). Chiral HPLC: 98.6% ee. [α]<sub class="stack">D</sub><sup class="stack">20</sup> +13.76° (<i>c</i> 1.06 g/100 mL, EtOH). <sup>1</sup>H NMR (D<sub>2</sub>O): 1.45 (t, <i>J</i> = 5.7 Hz, 1H), 1.62 (m, 1H), 1.71 (dd, <i>J</i> = 5.7, 6.0 Hz, 1H), 2.88 (dd, <i>J</i> = 6.0, 12.0 Hz, 1H), 3.01 (dd, <i>J</i> = 6.0, 12.0 Hz, 1H), 3.64 (dd, <i>J</i> = 6.0, 15.0 Hz, 1H), 3.91 (m, 2H), 4.16 (dd, <i>J</i> = 3.0, 15.0 Hz, 1H), 4.90 (d, <i>J</i> = 18.0 Hz, 1H), 5.00 (dd, <i>J</i> = 1.0, 9.0 Hz, 1H), 5.39 (m, 1H), 5.62 (m, 1H), 6.86 (m, 2H), 7.19 (m, 1H). <sup>13</sup>C NMR: 19.92, 25.67, 31.33, 41.66, 47.72, 50.93, 117.11, 118.47, 125.28, 125.43, 127.60, 131.51, 131.97, 142.86, 171.33. IR (KBr): 3423, 3191, 3074, 2834, 1616, 1469. MS: 277 (MH<sup>+</sup>). Anal. for (C<sub>15</sub>H<sub>20</sub>N<sub>2</sub>OS·HCl) C, H, N, S.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> <i>N</i>-Allyl-<i>N</i>-ethyl (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide Hydrochloride (<b>5a</b>)</h3><div class="NLM_p last">White powder. HPLC purity: 100% (220 nm) and 99.2% (254 nm). <sup>1</sup>H NMR (CDCl<sub>3</sub>, mixture of <i>E</i>/<i>Z</i> amides, ∼58:42): 0.98 and 1.09 (t, <i>J</i> = 7.2 Hz, 3H), 1.25 and 1.30 (t, <i>J</i> = 6.3 Hz, 1H), 1.70 and 1.81 (dd, <i>J</i> = 5.7, 9.0 Hz, 1H), 1.95 (m, 1H), 2.38 (m, 1H), 3.10 and 3.47 (dq, <i>J</i> = 6.9 Hz, 1H), 3.57 (1H), 3.77 (m, 1H), 3.84 and 3.90 (dd, <i>J</i> = 5.4, 16.5 Hz, 1H), 4.04 and 4.20 (dd, <i>J</i> = 4.8, 16.2 Hz, 1H), 5.10 (d, <i>J</i> = 18.5 Hz, 1H), 5.18 (m, 1H), 5.53 and 5.72 (m, 1H), 6.92 (m, 2H), 7.13 (m, 1H), 8.82 (brs, 3H). MS: 265 (MH<sup>+</sup>). Anal. for (C<sub>14</sub>H<sub>20</sub>N<sub>2</sub>OS·HCl) C, H, N, S.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-Ethyl-<i>N</i>-(2-fluoroallyl) (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide Hydrochloride (<b>5b</b>)</h3><div class="NLM_p last">White powder, mp = 140 °C (crystallized from isopropanol−ethyl acetate−diethyl ether). HPLC purity: 99.8% (220 and 254 nm). Chiral HPLC: 99.6% ee. [α]<sub class="stack">D</sub><sup class="stack">20</sup> +24.37° (<i>c</i> 1.04 g/100 mL, EtOH). <sup>1</sup>H NMR (D<sub>2</sub>O, mixture of <i>E</i>/<i>Z</i> amides, ∼60:40): 0.76 and 0.94 (t, <i>J</i> = 7.2 Hz, 3H), 1.45 (m, 1H), 1.68 (m, 2H), 2.90 (dd, <i>J</i> = 6.0, 12.0 Hz, 0.4H), 2.93 (m, 1.2H), 3.00 (dd, <i>J</i> = 6.0, 12.0 Hz, 0.4H), 3.17 and 3.38 (dq, <i>J</i> = 6.0 Hz, 1H), 3.33 and 3.57 (dq, <i>J</i> = 6.0 Hz, 1H), 3.87 and 4.00 (dd, <i>J</i> = 12, 18 Hz, 1H), 4.07 and 4.28 (dd, <i>J</i> = 12, 18 Hz, 1H), 4.27 and 4.44 (dd, <i>J</i> = 3.0, 9.0 Hz, 1H), 4.62 and 4.63 (dd, <i>J</i> = 3.0, 18.0 Hz, 1H), 6.85 (m, 2H), 7.17 (m, 1H). <sup>13</sup>C NMR: 11.15 and 12.01, 20.17 and 26.09, 25.68 and 26.09, 31.41, 40.98 and 43.52, 41.50 and 41.55, 44.58 and 48.14 (d, <i>J</i> = 33.0 Hz), 92.89 and 94.38 (d, <i>J</i> = 17.3 Hz), 124.94, 125.29 and 125.39, 127.63, 142.76, 159.58 and 159.88 (d, <i>J</i> = 255.8 Hz), 171.32 and 171.47. MS: 283 (MH<sup>+</sup>). Anal. for (C<sub>14</sub>H<sub>19</sub>FN<sub>2</sub>OS·HCl) C, H, N, S, Cl.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-Allyl-<i>N</i>-cyclopropyl (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide Hydrochloride (<b>5d</b>)</h3><div class="NLM_p last">White powder. HPLC purity: 98% (220 and 254 nm). <sup>1</sup>H NMR (CDCl<sub>3</sub>, mixture of <i>E</i>/<i>Z</i> amides, ∼38:62): 0.55−0.86 (m, 4H), 1.32 and 1.42 (t, <i>J</i> = 6.9 Hz, 1H), 1.68−2.00 (m, 2H), 2.24−2.58 (m, 1H), 2.65 (m, 1H), 3.72 (m, 1H), 3.82−4.16 (m, 2H), 5.10 (m, 2H), 5.58 and 5.78 (m, 1H), 6.84 (m, 2H), 7.11 (m, 1H), 8.66 (brs, 3H). MS: 277 (MH<sup>+</sup>). Anal. for (C<sub>15</sub>H<sub>20</sub>N<sub>2</sub>OS·HCl·0.3H<sub>2</sub>O) C, H, N, S.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-Allyl-<i>N</i>-(2-thiazolyl)methyl (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide Hydrochloride (<b>5e</b>)</h3><div class="NLM_p last">White powder. HPLC purity: 100% (220 and 254 nm). Chiral HPLC 99.1% ee. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, mixture of <i>E</i>/<i>Z</i> amides, ∼76:34): 1.52−1.76 (m, 3H), 2.74 (m, 1H), 2.96 (m, 1H), 3.65−4.32 (m, 2H), 4.52 (d, <i>J</i> = 15.6 Hz, 0.76H), 4.87 (d, <i>J</i> = 15.6 Hz, 1H), 4.95−5.18 (m, 2.24H), 5.43 and 5.65 (m, 1H), 6.92−7.15 (m, 2H), 7.40 and 7.42 (dd, <i>J</i> = 1.5, 4.8 Hz, 1H), 7.67 (d, <i>J</i> = 3.6 Hz, 1H), 7.71 and 7.73 (d, <i>J</i> = 3.6 Hz, 1H), 8.04 (brs, 3H). MS: 334 (MH<sup>+</sup>). Anal. for (C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>OS<sub>2</sub>·1.8HCl·0.2H<sub>2</sub>O) C, H, N, S, Cl.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-Ethyl-<i>N</i>-propargyl (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide Hydrochloride (<b>5f</b>)</h3><div class="NLM_p last">White powder. HPLC purity: 98.7% (220 and 254 nm). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, mixture of <i>E</i>/<i>Z</i> amides, ∼56:44): 0.86 and 1.07 (t, <i>J</i> = 7.2 Hz, 3H), 1.50−1.75 (m, 3H), 2.64 (m, 1H), 2.95 (m, 1H), 3.16 and 3.30 (t, <i>J</i> = 2.4 Hz, 1H), 3.20−3.68 (m, 2H), 3.98 and 4.00 (dd, <i>J</i> = 2.4, 17.7 Hz, 1H), 4.23 and 4.28 (dd, <i>J</i> = 2.4, 17.7 Hz, 1H), 6.94 (m, 2H), 7.39 (m, 1H), 8.12 (brs, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 12.13 and 12.68, 21.38 and 21.48, 32.39 and 33.14, 33.64, 37.58, 40.55 and 42.13, 43.47 and 43.91, 71.56 and 72.82, 123.46, 123.79, 124.38, 127.26 and 127.35, 141.5, 171.0. MS: 263 (MH<sup>+</sup>). Anal. for (C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>OS·HCl·0.3H<sub>2</sub>O) C, H (calcd 6.49%, found 7.06%), N, S, Cl.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>,<i>N</i>-Dipropargyl (1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide Hydrochloride (<b>5g</b>)</h3><div class="NLM_p last">White powder. HPLC purity: 99% (220 and 254 nm). Chiral HPLC 98% ee. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 1.54−1.78 (m, 3H), 2.57 (m, 1H), 3.05 (m, 1H), 3.25 (t, <i>J</i> = 2.1 Hz, 1H), 3.36 (t, <i>J</i> = 2.1 Hz, 1H), 4.07 and 4.19 (dd, <i>J</i> = 2.1, 17.1 Hz, 1H), 4.40 and 4.36 (dd, <i>J</i> = 1.8, 18.0 Hz, 1H), 6.96 (m, 2H), 7.41 (m, 1H), 8.04 (brs, 3H). MS: 273 (MH<sup>+</sup>). Anal. for (C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>OS·1.2HCl·0.1H<sub>2</sub>O) C, H, N (calcd 8.91%, found 9.50%), S, Cl.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-[(1<i>R</i>,2<i>R</i>)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarbonyl]isoindoline Hydrochloride (<b>5h</b>)</h3><div class="NLM_p last">White powder. HPLC purity: 100% (220 and 254 nm). Chiral HPLC 96% ee. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 1.41 (t, <i>J</i> = 5.7 Hz, 1H), 1.81 (dd, <i>J</i> = 5.7, 9.0 Hz, 1H), 2.00 (m, 1H), 2.66 (m, 1H), 3.69 (m, 1H), 4.70 (d, <i>J</i> = 14.7 Hz, 1H), 4.77 (s, 2H), 4.92 (d, <i>J</i> = 14.4 Hz, 1H), 6.87 (dd, <i>J</i> = 3.6, 5.8 Hz, 1H), 6.97 (dd, <i>J</i> = 1.2, 3.3 Hz, 1H), 7.10 (dd, <i>J</i> = 0.9, 5.4 Hz, 1H), 7.15−7.30 (m, 4H), 8.78 (brs, 3H). <sup>13</sup>C NMR: 20.31, 26.82, 32.14, 32.87, 52.92, 53.34, 122.77, 123.24, 124.80, 125.74, 127.60, 127.91, 128.10, 135.66, 136.00, 142.01, 169.11. MS: 299 (MH<sup>+</sup>). Anal. for (C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>OS·1.2HCl) C, H, N, S.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Monoamine Transporter Inhibition Assay Methods</h3><div class="NLM_p">The norepinephrine, dopamine, and serotonin transporters were individually expressed in stably transfected HEK293 cell lines and grown in Dulbecco’s modified Eagles medium (DMEM) (Cellgro, 15-013-CV) with the following supplements: 1% HEPES (Cellgro, MT 25-060-Cl), 1% <span class="smallcaps smallerCapital">l</span>-glutamine (Cellgro, MT 25-005-Cl), 1% sodium pyruvate (Cellgro, MT 25−000Cl), 1% Pen/Strep (Cellgro, MT 30-001-Cl), 10% heat-inactivated fetal bovine serum (FBS) (Hyclone, Logan, UT), 250 μg/mL G418 (Cellgro, 61-234-RG).</div><div class="NLM_p last">The day before the assay, solid white 96-well TC-treated sterile plates (Costar, 3917) that had been coated with 0.01% poly-<span class="smallcaps smallerCapital">d</span>-lysine (Sigma, P6407) and 0.01% collagen (BD Biosciences, 354236) were seeded with cells at a density of 20 000 cells/well. The cells were allowed to attach overnight in a 37 °C incubator (7.5% CO<sub>2</sub>). On the day of the assay, media were removed, and cells were washed with phosphate buffered saline. The cells were then incubated at room temperature for 20 min with varying concentrations of competing ligand in a total volume of 150 μL of transport buffer (20 mM HEPES, 122 mM NaCl, 3 mM KCl, 1.3 mM CaCl<sub>2</sub>, 1.2 mM KH<sub>2</sub>PO<sub>4</sub>, 0.4 mM MgSO<sub>4</sub>, 1 mM ascorbic acid, 0.1 mM pargyline, 0.1 mM tropolone). Radioligand was then added to the cells for a total volume of 200 μL, and cells were incubated at room temperature for an additional 20 min. (Levo[ring-2,5,6-<sup>3</sup>H]norepinephrine (52 Ci/mmol, PerkinElmer, NET-678) was used for NET, 3,4-[ring-2,5,6-<sup>3</sup>H]dihydroxyphenylethylamine (50 Ci/mmol, PerkinElmer, NET-673) was used for DAT, and [α,β-<sup>3</sup>H(N)]-5-hydroxytryptamine (30 Ci/mmol, PerkinElmer, NET-498) was used for SERT.) After incubation, the transport buffer was quickly aspirated from the plates, and the cells were washed twice with 4 °C wash buffer (20 mM HEPES, 280 mM <span class="smallcaps smallerCapital">d</span>-mannitol, 5.4 mM KCl, 1.8 mM CaCl<sub>2</sub>, 0.8 mM MgSO<sub>4</sub>, 1 mM ascorbic acid, 0.1 mM pargyline, 0.1 mM tropolone). Cells were treated with 50 μL of 5% sodium dodecyl sulfate solution (Sigma, L4522) and 200 μL of Microscint scintillation fluid. Plates were shaken vigorously overnight before monitoring radioligand in a TopCount-NXT (Packard) microplate scintillation counter. Data were analyzed by nonlinear, least-squares curve fitting algorithms using ActivityBase (IDBS, Guildford, Surrey, U.K.).</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> hERG Patch-Clamp Assay</h3><div class="NLM_p last">The hERG potassium current was recorded from a hERG/HEK cell line using established patch-clamp methods. The effects of test compounds on the hERG current were determined at the end of a 5 min application. Test compounds were tested at six concentrations (0.1 nM, 1 nM, 10 nM, 100 nM, 1 μM, and 10 μM). Cisapride (30 nM) was used as a positive control.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Metabolic Stability in Rat and Human Liver Microsomes</h3><div class="NLM_p last">Pooled male human and rat liver microsomes (0.5 mg/mL for human and 0.1 mg/mL for rat; <i>n</i> > 10; mixed gender) were incubated at 37 °C with the test compound in the presence of an NADPH-generating system containing 50 mM, pH 7.4, potassium phosphate buffer, 3 mM magnesium chloride, 1 mM EDTA, 1 mM NADP, 5 mM G-6-P, and 1 unit/mL G-6-PD. Incubations were conducted with 1 μM of each compound (0.01% DMSO) with a total volume of 250 μL, in duplicate at each time point (0, 5, 10, 20, 40, and 60 min). Reactions were stopped by the addition of 0.3 mL of acetonitrile (ACN) containing a proprietary internal standard. Precipitated proteins were removed by centrifugation for 15 min at 3000 rpm, and the supernatant fluid (∼0.1 mL) was analyzed by LCMS for the percentage of parent compound remaining. The in vitro initial rates of metabolism were scaled using constants, such as microsomal protein/g of liver, g of liver/kg of body weight, and liver blood flow, to predict systemic clearance and maximum predicted percent bioavailability. These calculations from nonlinear regression assume that liver metabolism alone is the determinant of bioavailability.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Pharmacokinetic Characterization</h3><div class="NLM_p">The pharmacokinetic profiles of selected compounds were determined in animals (<i>N</i> = 3 time points at a typical dose of 30 mg/kg for po or 5 mg/kg for iv). Compounds were dosed as a hydrochloride salt in water. Composite sampling was used to collect samples. Terminal blood samples were taken from treated animals at 9 time points ranging from predose to 24 h (0, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h) postdose. Brain samples were collected at 1 and 4 h after po dosing in rats for all compounds.</div><div class="NLM_p">For plasma samples, the compound was extracted via a protein precipitation assay by adding 130 mL of acetonitrile (CAN) and 30 mL of internal standard in 50 μL of mouse plasma (EDTA). Standards and QCs were prepared by drying 50 mL of spiked aqueous solutions and reconstituting with 50 mL of blank plasma. For brain samples, the whole brain was homogenized in 2.0 mL of ACN/H<sub>2</sub>O/formic acid (v/v, 60/40/0.1) containing 50 mL of internal standard, and the supernatant was collected and injected into an LC−MS/MS system for analysis. Brain standards and QCs were prepared by adding 1.0 mL of spiked aqueous solutions (prepared in 60/40 ACN/H<sub>2</sub>O), 1.0 mL of ACN/H<sub>2</sub>O/formic acid (v/v, 60/40/0.1) and 50 mL of internal standard into a whole blank brain. Standards and QCs for both plasma and brain were processed and analyzed at the same time and in exactly the same way as the analytical samples. The compound was measured using a specific and sensitive HPLC/MS assay that offered linear ranges of 1−1000 ng/mL for plasma sample analysis and 1−500 ng/mL for brain sample analysis. The lower limit of quantitation (LLOQ) was 1 ng/mL for the study. Quantification for both plasma and brain samples was performed by fitting peak area ratios to a weighted (1/<i>x</i>) linear calibration curve.</div><div class="NLM_p last">Descriptive pharmacokinetics were derived and evaluated on the basis of the mean plasma concentrations (<i>N</i> = 3 time points). A noncompartmental model in ActivityBase with linear trapezoidal rule was used to perform all pharmacokinetic analyses pertaining to this manuscript.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Bioanalysis</h3><div class="NLM_p last">The LC−MS/MS system equipped with Agilent 1100 HPLC system was coupled to a CTC PAL autoinjector (Leap Technologies, Carrboro, NC) and a Sciex API 4000 triple quadruple mass spectrometer. Samples were eluted at 0.45 mL/min using a mobile phase consisting of solution A (0.1% formic acid in water) and solution B (0.1% formic acid in acetonitrile) with a fast gradient (0−0.1 min, 5% B; 0.1−1.0 min, 5−95% B; hold to 2.5 min; 2.5−2.7 min, 95−5% B; hold to 3.5 min) and a column temperature of 20 °C. The HPLC column used for this assay was Agilent Zorbax SB-C18 column, 2.1 mm × 50 mm, with a particle size of 5 μm. Electrospray ionization source was used for detection at a positive MRM (multiple reaction monitoring) mode. Quantification was performed by fitting peak area ratios (peak of parent analyte vs peak of the internal standard) to a weighted (1/<i>x</i>) linear calibration curve.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Formalin Model</h3><div class="NLM_p last">All animal studies were conducted using protocols approved by the Neurocrine IACUC committee. The formalin test was conducted using the automated nociception analyzer (Department of Anesthesiology, University of California, San Diego) and performed as described by Yaksh et al.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> One hour prior to testing, male rats (CD, Charles River Laboratories, 250−300 g) were dosed orally with either vehicle (5% Cremophor EL, Sigma, St. Louis, MO in MilliQ water) or test compound at indicated doses and fitted with a metal band on their left hind paw. At testing, rats were injected subcutaneously on dorsal surface of the left hind paw with 50 μL of 5% formalin in saline and placed on the nociception analyzer. The number of flinches per minute was tabulated for 1 h. Here, we report flinches from 10−40 min after formalin injection, the phase referred to as phase IIA, the portion of the response that corresponds to sensitization of central processing of nociceptive inputs. Compound effects on the number of flinches in phase IIA were analyzed by a one-way analysis of variance (ANOVA) (NCSS 2001, Kaysville, UT). Significant effects were analyzed by Dunnett’s post hoc comparison to vehicle treatment.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Mechanical Hyperalgesia in Spinal Nerve Ligated Rats</h3><div class="NLM_p last">Spinal nerve ligation (SNL) neuropathy was induced in male rats (Sprague−Dawley, Harlan, 150−175 g). Briefly, the left L5 and L6 spinal nerves distal to the dorsal root ganglion were tightly ligated with 6−0 silk suture.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> SNL rats were tested for mechanical hyperalgesia using the pin-prick method.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The length of time the paw was held off the grid floor was measured with the computer program Xnote Stopwatch, version 1.4. Zero seconds was assigned when there was no paw withdrawal. The baseline score was determined from the average of five trials. Rats that met criteria (withdrawal durations greater than 1.5 s)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> were assigned to treatment groups by counterbalancing their baseline times. Animals were dosed orally with either vehicle (5% Cremophor in MilliQ water) or test compound at indicated doses. One hour later withdrawal response to the pin prick was assessed by the average of three trials. Drug effects are analyzed by a two-way ANOVA with treatment and time as variables. Significant effects are analyzed by Dunnett’s post hoc comparison (NCSS 2001, Kaysville, UT).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/jm8009537">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data of final compounds and HPLC chromatograms of <b>5g</b> and <b>5h</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8009537/suppl_file/jm8009537_si_001.pdf">jm8009537_si_001.pdf (667.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm8009537" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chen Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#791a1a111c1739171c0c0b161a0b10171c571a1614"><span class="__cf_email__" data-cfemail="71121219141f311f1404031e1203181f145f121e1c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Dyck</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junko Tamiya</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Jovic</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca R. Pick</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margaret J. Bradbury</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie O’Brien</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Wen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Johns</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ajay Madan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beth A. Fleck</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan C. Foster</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Binfeng Li</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingzhu Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joe A. Tran</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Troy Vickers</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Grey</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Saunders</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, Pharmacology, Neuroscience, and Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are indebted to Dr. Robert Petroski for performing the <i>h</i>ERG assay and Paddi Ekhlassi for the measurement of physicochemical properties.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Iversen, L.</span><span> </span><span class="NLM_article-title">Neurotransmitter transporters and their impact on the development of psychopharmacology</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">S82</span><span class="NLM_x">–</span> <span class="NLM_lpage">S88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S82-S88&author=L.+Iversen&title=Neurotransmitter+transporters+and+their+impact+on+the+development+of+psychopharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%26atitle%3DNeurotransmitter%2520transporters%2520and%2520their%2520impact%2520on%2520the%2520development%2520of%2520psychopharmacology%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3DS82%26epage%3DS88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Runyon, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span> </span><span class="NLM_article-title">Dopamine transporter ligands: recent developments and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.2174%2F156802606778249775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=17017960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1825-1843&author=S.+P.+Runyonauthor=F.+I.+Carroll&title=Dopamine+transporter+ligands%3A+recent+developments+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transporter ligands: recent developments and therapeutic potential</span></div><div class="casAuthors">Runyon, Scott P.; Carroll, F. Ivy</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1825-1843</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The dopamine transporter (DAT) is a target for the development of pharmacotherapies for a no. of central disorders including Parkinson's disease, Alzheimer's disease, schizophrenia, Tourette's syndrome, Lesch-Nyhan disease, attention deficit hyperactivity disorder (ADHD), obesity, depression, and stimulant abuse as well as normal aging.  Considerable effort continues to be devoted to the development of new ligands for the DAT.  In this review, we present some of the more interesting ligands developed during the last few years from the 3-phenytropane, 1,4-dialkylpiperazine, phenylpiperidine, and benztropine classes of DAT uptake inhibitors as well as a few less studied misc. DAT uptake inhibitors.  Studies related to the therapeutic potential of some of the more studied compds. are presented.  A few of the compds. have been studied as pharmacotherapies for Parkinson's disease, ADHD, and obesity.  However, most of the drug discovery studies have been directed toward pharmacotherapies for stimulant abuse (mainly cocaine).  A no. of the compds. showed decreased cocaine maintained responding in rhesus monkeys trained to self-administer cocaine.  One compd., GBR 12909, was evaluated in a Phase 1 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtevTL8FZC3rVg90H21EOLACvtfcHk0lhYIbRuZedKuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurjE&md5=972cacd0661e7394126d698da4407152</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F156802606778249775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249775%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26atitle%3DDopamine%2520transporter%2520ligands%253A%2520recent%2520developments%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1825%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gibson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettinger, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crismon, M. L.</span><span> </span><span class="NLM_article-title">Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=1134-1142&author=A.+P.+Gibsonauthor=T.+L.+Bettingerauthor=N.+C.+Patelauthor=M.+L.+Crismon&title=Atomoxetine+versus+stimulants+for+treatment+of+attention+deficit%2Fhyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DA.%2BP.%26aulast%3DBettinger%26aufirst%3DT.%2BL.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DCrismon%26aufirst%3DM.%2BL.%26atitle%3DAtomoxetine%2520versus%2520stimulants%2520for%2520treatment%2520of%2520attention%2520deficit%252Fhyperactivity%2520disorder%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2006%26volume%3D40%26spage%3D1134%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Frampton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plosker, G. L.</span><span> </span><span class="NLM_article-title">Duloxetine: a review of its use in the treatment of major depressive disorder</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=581-609&author=J.+E.+Framptonauthor=G.+L.+Plosker&title=Duloxetine%3A+a+review+of+its+use+in+the+treatment+of+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrampton%26aufirst%3DJ.%2BE.%26aulast%3DPlosker%26aufirst%3DG.%2BL.%26atitle%3DDuloxetine%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520the%2520treatment%2520of%2520major%2520depressive%2520disorder%26jtitle%3DCNS%2520Drugs%26date%3D2007%26volume%3D21%26spage%3D581%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span> </span><span class="NLM_article-title">SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants</span> <span class="citation_source-journal">CNS Spectrosc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=16142213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADC%252BD2MvntFGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=732-347&author=S.+M.+Stahlauthor=M.+M.+Gradyauthor=C.+Moretauthor=M.+Briley&title=SNRIs%3A+their+pharmacology%2C+clinical+efficacy%2C+and+tolerability+in+comparison+with+other+classes+of+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants</span></div><div class="casAuthors">Stahl Stephen M; Grady Meghan M; Moret Chantal; Briley Mike</div><div class="citationInfo"><span class="NLM_cas:title">CNS spectrums</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">732-47</span>
        ISSN:<span class="NLM_cas:issn">1092-8529</span>.
    </div><div class="casAbstract">The class of serotonin and norepinephrine reuptake inhibitors (SNRIs) now comprises three medications: venlafaxine, milnacipran, and duloxetine.  These drugs block the reuptake of both serotonin (5-HT) and norepinephrine with differing selectivity.  Whereas milnacipran blocks 5-HT and norepinephrine reuptake with equal affinity, duloxetine has a 10-fold selectivity for 5-HT and venlafaxine a 30-fold selectivity for 5-HT.  All three SNRIs are efficacious in treating a variety of anxiety disorders.  There is no evidence for major differences between SNRIs and SSRIs in their efficacy in treating anxiety disorders.  In contrast to SSRIs, which are generally ineffective in treating chronic pain, all three SNRIs seem to be helpful in relieving chronic pain associated with and independent of depression.  Tolerability of an SNRI at therapeutic doses varies within the class.  Although no direct comparative data are available, venlafaxine seems to be the least well-tolerated, combining serotonergic adverse effects (nausea, sexual dysfunction, withdrawal problems) with a dose-dependent cardiovascular phenomenon, principally hypertension.  Duloxetine and milnacipran appear better tolerated and essentially devoid of cardiovascular toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_ihXu61xcczW1zwg2yUK5fW6udTcc2eY8VUQthuIslbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvntFGjsQ%253D%253D&md5=b4a197b2730c0669c0a23dc7c75be4c7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DGrady%26aufirst%3DM.%2BM.%26aulast%3DMoret%26aufirst%3DC.%26aulast%3DBriley%26aufirst%3DM.%26atitle%3DSNRIs%253A%2520their%2520pharmacology%252C%2520clinical%2520efficacy%252C%2520and%2520tolerability%2520in%2520comparison%2520with%2520other%2520classes%2520of%2520antidepressants%26jtitle%3DCNS%2520Spectrosc.%26date%3D2005%26volume%3D10%26spage%3D732%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mochizucki, D.</span><span> </span><span class="NLM_article-title">Serotonin and noradrenaline reuptake inhibitors in animal models of pain</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">S15</span><span class="NLM_x">–</span> <span class="NLM_lpage">S19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=S15-S19&author=D.+Mochizucki&title=Serotonin+and+noradrenaline+reuptake+inhibitors+in+animal+models+of+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMochizucki%26aufirst%3DD.%26atitle%3DSerotonin%2520and%2520noradrenaline%2520reuptake%2520inhibitors%2520in%2520animal%2520models%2520of%2520pain%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2004%26volume%3D19%26spage%3DS15%26epage%3DS19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bisserbe, J. C.</span><span> </span><span class="NLM_article-title">Clinical utility of milnacipran in comparison with other antidepressants</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S43</span><span class="NLM_x">–</span> <span class="NLM_lpage">S50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=S43-S50&author=J.+C.+Bisserbe&title=Clinical+utility+of+milnacipran+in+comparison+with+other+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBisserbe%26aufirst%3DJ.%2BC.%26atitle%3DClinical%2520utility%2520of%2520milnacipran%2520in%2520comparison%2520with%2520other%2520antidepressants%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2002%26volume%3D17%26spage%3DS43%26epage%3DS50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Neil Vaishnavi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plott, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranzler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, M. J.</span><span> </span><span class="NLM_article-title">Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=320-322&author=S.+Neil+Vaishnaviauthor=C.+B.+Nemeroffauthor=S.+J.+Plottauthor=S.+G.+Raoauthor=J.+Kranzlerauthor=M.+J.+Owens&title=Milnacipran%3A+a+comparative+analysis+of+human+monoamine+uptake+and+transporter+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeil%2BVaishnavi%26aufirst%3DS.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26aulast%3DPlott%26aufirst%3DS.%2BJ.%26aulast%3DRao%26aufirst%3DS.%2BG.%26aulast%3DKranzler%26aufirst%3DJ.%26aulast%3DOwens%26aufirst%3DM.%2BJ.%26atitle%3DMilnacipran%253A%2520a%2520comparative%2520analysis%2520of%2520human%2520monoamine%2520uptake%2520and%2520transporter%2520binding%2520affinity%26jtitle%3DBiol.%2520Psychiatry%26date%3D2004%26volume%3D55%26spage%3D320%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Rooks, D. S.</span><span> </span><span class="NLM_article-title">Fibromyalgia treatment update</span> <span class="citation_source-journal">Curr. Opin. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FnvF2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=111-117&author=D.+S.+Rooks&title=Fibromyalgia+treatment+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Fibromyalgia treatment update</span></div><div class="casAuthors">Rooks Daniel S</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in rheumatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-7</span>
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Fibromyalgia is a common chronic pain disorder characterized by complex symptomatology and few consistently effective treatments.  The purpose of this review is to highlight the recent literature from April 2005 through September 2006 involving treatment options.  RECENT FINDINGS:  Prior evidence suggests that medication and self-management approaches to care can improve symptoms, function and well-being in this patient population.  Recent studies examining the efficacy of two serotonin and norepinephrine-reuptake inhibitors--duloxetine and milnacipran--and the anticonvulsant pregabalin are encouraging.  Studies evaluating different forms of exercise continue to support the belief that increased physical activity is an essential component of any treatment plan for the patient with fibromyalgia.  Three studies added to the understanding of treatment adherence.  Finally, three studies evaluating the efficacy of acupuncture in the treatment of fibromyalgia showed conflicting results, but added to the knowledge needed for clinicians to have substantive conversations with patients.  SUMMARY:  Recent studies support the recommendation of a multimodal approach to treatment involving individualized, evidence-based pharmacotherapy and self-management.  Treatment goals should include the improvement of symptoms, primarily pain and sleep, and the promotion of positive health behaviors with the aim of improving physical function and emotional well-being.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7mZlo5bGGz9enUz0lpNqnfW6udTcc2eYBHdRFvJDdbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FnvF2jsw%253D%253D&md5=b2fc1b3635aba5f1d04db6d18761d71d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRooks%26aufirst%3DD.%2BS.%26atitle%3DFibromyalgia%2520treatment%2520update%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2007%26volume%3D19%26spage%3D111%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Leo, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, V. L.</span><span> </span><span class="NLM_article-title">Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsVagu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=637-642&author=R.+J.+Leoauthor=V.+L.+Brooks&title=Clinical+potential+of+milnacipran%2C+a+serotonin+and+norepinephrine+reuptake+inhibitor%2C+in+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain</span></div><div class="casAuthors">Leo, Raphael J.; Brooks, Victoria L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">637-642</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Milnacipran is a serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor currently available for use as an antidepressant in several countries.  Phase III clin. trials are currently underway to assess its potential role in the treatment of fibromyalgia syndrome, and in pursuit of US Food and Drug Administration approval for this indication.  Evidence has accumulated suggesting that in animal models, milnacipran may exert pain-mitigating influences involving NE- and 5-HT-related processes at supraspinal, spinal and peripheral levels of pain transmission.  Preliminary evidence suggests that milnacipran may be useful in mitigating pain and fatigue assocd. with fibromyalgia.  However, its role in addressing comorbidities assocd. with fibromyalgia, including visceral pain and migraine, has yet to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhSpYMSSy_7Vg90H21EOLACvtfcHk0liAWHP6E1XRJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsVagu7Y%253D&md5=41865ee926e9d440b46eb5be0e919ab3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DR.%2BJ.%26aulast%3DBrooks%26aufirst%3DV.%2BL.%26atitle%3DClinical%2520potential%2520of%2520milnacipran%252C%2520a%2520serotonin%2520and%2520norepinephrine%2520reuptake%2520inhibitor%252C%2520in%2520pain%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D637%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><div class="note"><p class="first last">Calculated log <i>P</i> values were 1.2 for milnacipran and 3.3 for atomoxetine using ACD software.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Calculated+log%E2%80%89P+values+were+1.2+for+milnacipran+and+3.3+for+atomoxetine+using+ACD+software."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of milnacipran in comparison with other antidepressants</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADyaK2s%252FotFyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1996&pages=15-27&issue=Suppl.+4&author=C.+Puozzoauthor=B.+E.+Leonard&title=Pharmacokinetics+of+milnacipran+in+comparison+with+other+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of milnacipran in comparison with other antidepressants</span></div><div class="casAuthors">Puozzo C; Leonard B E</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">11 Suppl 4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-27</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">Despite the large number of antidepressants currently available, it is still necessary to develop new drugs that combine the efficacy of the older antidepressant with improved safety, tolerability and therapeutic profile that will allow them to be used in depressed patients who are elderly or with cardiac, renal or hepatic disease.  This article reviews the pharmacokinetic characteristics of the tricyclic antidepressants, the selective serotonin reuptake inhibitors (SSRIs) and more recently introduced antidepressants such as venlafaxine and nefazodone.  Milnacipran (Ixel), a novel drug, combines antidepressant efficacy with some unique pharmacokinetic features.  A summary of its pharmacokinetic profile shows that milnacipran has a high bioavailability, low plasma protein binding and that it is largely eliminated in the urine as parent drug or as a glucuronide.  These features suggest that the likelihood of interactions with other drugs given concurrently is lower than would occur with most second generation antidepressants and the tricyclic antidepressants.  Furthermore, studies in patients with liver dysfunction, and in the elderly, suggest that dose adjustment is not necessary when milnacipran is administered to these patients.  The decrease in milnacipran elimination is correlated to the degree of renal impairment, allowing adjustment of schedules.  In comparison to earlier antidepressants, milnacipran combines efficacy and a relatively low side-effect profile with the added advantage of fewer interactions with drugs that may be given concurrently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMqDHTs6pfx_3jf77P2BG3fW6udTcc2eYMBy-4UinyZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FotFyrsg%253D%253D&md5=4cdde68e6ed61298862f038901cbfd74</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DPharmacokinetics%2520of%2520milnacipran%2520in%2520comparison%2520with%2520other%2520antidepressants%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1996%26volume%3D11%26issue%3DSuppl.%25204%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panconi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span> </span><span class="NLM_article-title">Pharmacology and pharmacokinetics of milnacipran</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S25</span><span class="NLM_x">–</span> <span class="NLM_lpage">S35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=S25-S35&author=C.+Puozzoauthor=E.+Panconiauthor=D.+Deprez&title=Pharmacology+and+pharmacokinetics+of+milnacipran"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DPanconi%26aufirst%3DE.%26aulast%3DDeprez%26aufirst%3DD.%26atitle%3DPharmacology%2520and%2520pharmacokinetics%2520of%2520milnacipran%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2002%26volume%3D17%26spage%3DS25%26epage%3DS35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosillon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deroubaix, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span> </span><span class="NLM_article-title">Lack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressants</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFSktb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=977-988&author=C.+Puozzoauthor=S.+Lensauthor=C.+Rehauthor=K.+Michaelisauthor=D.+Rosillonauthor=X.+Deroubaixauthor=D.+Deprez&title=Lack+of+interaction+of+milnacipran+with+the+cytochrome+p450+isoenzymes+frequently+involved+in+the+metabolism+of+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants</span></div><div class="casAuthors">Puozzo, Christian; Lens, Simone; Reh, Christian; Michaelis, Karl; Rosillon, Dominique; Deroubaix, Xavier; Deprez, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">977-988</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">To compare the pharmacokinetics of milnacipran in extensive metabolisers (EMs) and poor metabolisers (PMs) of sparteine and mephenytoin, and to assess the influence of multiple administrations of milnacipran on the activity of cytochrome P 450 (CYP) isoenzymes through its own metab. and through various probes, namely CYP2D6 (sparteine/dextromethorphan), CYP2C19 (mephenytoin), CYP1A2 (caffeine) and CYP3A4 (endogenous 6-β-hydroxy-cortisol excretion).  Twenty-five healthy subjects, 12 EMs for both sparteine/dextromethorphan and mephenytoin, nine EMs for mephenytoin and PMs for sparteine/dextromethorphan (PM2D6) and four PMs for mephenytoin and EMs for sparteine/dextromethorphan (PM2C19) were administered milnacipran as a single 50 mg capsule on day 1 followed by a 50 mg capsule twice daily for 7 days.  The pharmacokinetics of milnacipran and its oxidative metabolites were assessed after the first dose (day 1) and after multiple administration (day 8), and were compared for differences between CYP2D6 and CYP2C19 PMs and EMs.  Metabolic tests were performed before (day -2), during (days 1 and 8) and after (day 20) milnacipran administration.  Milnacipran steady state was rapidly achieved.  Metab. was limited: approx. 50% unchanged drug, 30% as glucuronide and 20% as oxidative metabolite (mainly F2800 the N-dealkyl metabolite).  Milnacipran administration to PM2D6 and PM2C19 subjects did not increase parent drug exposure or decrease metabolite exposure.  Milnacipran oxidative metab. is not mediated through CYP2D6 or CYP2C19 polymorphic pathways nor does it significantly interact with CYP1A2, CYP2C19, CYP2D6 or CYP3A4 activities.  Limited reciprocal pharmacokinetic interaction between milnacipran and CYP isoenzymes would confer flexibility in the therapeutic use of the drug when combined with antidepressants.  Drug-drug interaction risk would be low, even if the combined treatments were likely to inhibit CYP2D6 and CYP2C19 isoenzyme activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVvpa0a8FGrVg90H21EOLACvtfcHk0liWWynGE_OGvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFSktb3J&md5=b7140b28e2079ca8c40dcb8e7abadeef</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DLens%26aufirst%3DS.%26aulast%3DReh%26aufirst%3DC.%26aulast%3DMichaelis%26aufirst%3DK.%26aulast%3DRosillon%26aufirst%3DD.%26aulast%3DDeroubaix%26aufirst%3DX.%26aulast%3DDeprez%26aufirst%3DD.%26atitle%3DLack%2520of%2520interaction%2520of%2520milnacipran%2520with%2520the%2520cytochrome%2520p450%2520isoenzymes%2520frequently%2520involved%2520in%2520the%2520metabolism%2520of%2520antidepressants%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2005%26volume%3D44%26spage%3D977%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Preskorn, S. H.</span><span> </span><span class="NLM_article-title">Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitor</span> <span class="citation_source-journal">J. Psychiatr. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1097%2F00131746-200403000-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=15330407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADC%252BD2cvisFWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=119-126&author=S.+H.+Preskorn&title=Milnacipran%3A+a+dual+norepinephrine+and+serotonin+reuptake+pump+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitor</span></div><div class="casAuthors">Preskorn Sheldon H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric practice</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-26</span>
        ISSN:<span class="NLM_cas:issn">1527-4160</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe_m3nZG_f0f6AExegM5LLfW6udTcc2eYMBy-4UinyZrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvisFWitw%253D%253D&md5=737ed2988f90e4766d2f73bd72c1fed9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2F00131746-200403000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00131746-200403000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26atitle%3DMilnacipran%253A%2520a%2520dual%2520norepinephrine%2520and%2520serotonin%2520reuptake%2520pump%2520inhibitor%26jtitle%3DJ.%2520Psychiatr.%2520Pract.%26date%3D2004%26volume%3D10%26spage%3D119%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><div class="note"><p class="first last">The following data were reported by Moret et al. for milnacipran inhibition of monoamine uptake in rat brain slice: NET IC<sub>50</sub> = 100 nM, SERT IC<sub>50</sub> = 203 nM (</p></div><span class="NLM_contrib-group">Moret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charveron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couzinier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span> </span><span class="NLM_article-title">Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span><div class="note"><p class="first last">)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1985&pages=1211-1219&author=C.+Moretauthor=M.+Charveronauthor=J.+P.+Finbergauthor=J.+P.+Couzinierauthor=M.+Briley&title=Biochemical+profile+of+midalcipran+%28F+2207%29%2C+1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane+%28Z%29+hydrochloride%2C+a+potential+fourth+generation+antidepressant+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoret%26aufirst%3DC.%26aulast%3DCharveron%26aufirst%3DM.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DCouzinier%26aufirst%3DJ.%2BP.%26aulast%3DBriley%26aufirst%3DM.%26atitle%3DBiochemical%2520profile%2520of%2520midalcipran%2520%2528F%25202207%2529%252C%25201-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane%2520%2528Z%2529%2520hydrochloride%252C%2520a%2520potential%2520fourth%2520generation%2520antidepressant%2520drug%26jtitle%3DNeuropharmacology%26date%3D1985%26volume%3D24%26spage%3D1211%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><div class="note"><p class="first last">Mochizuki et al. reported the following values at rat synaptosomes: NET IC<sub>50</sub> = 29.6 nM, SERT IC<sub>50</sub> = 28 nM; DAT IC<sub>50</sub> > 10 000 nM (</p></div><span class="NLM_contrib-group">Mochizuki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, N.</span><span> </span><span class="NLM_article-title">Neurochemical and behavioural characterization of milnacipran, a serotonin and norepinephrine reuptake inhibitor in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><div class="note"><p class="first last">)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2002&pages=323-332&author=D.+Mochizukiauthor=R.+Tsujitaauthor=S.+Yamadaauthor=K.+Kawasakiauthor=Y.+Otsukaauthor=S.+Hashimotoauthor=T.+Hattoriauthor=Y.+Kitamuraauthor=N.+Miki&title=Neurochemical+and+behavioural+characterization+of+milnacipran%2C+a+serotonin+and+norepinephrine+reuptake+inhibitor+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMochizuki%26aufirst%3DD.%26aulast%3DTsujita%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKawasaki%26aufirst%3DK.%26aulast%3DOtsuka%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DMiki%26aufirst%3DN.%26atitle%3DNeurochemical%2520and%2520behavioural%2520characterization%2520of%2520milnacipran%252C%2520a%2520serotonin%2520and%2520norepinephrine%2520reuptake%2520inhibitor%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2002%26volume%3D162%26spage%3D323%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><div class="note"><p class="first last">Neil Vaishnavi et al. reported NET IC<sub>50</sub> = 68 nM, SERT IC<sub>50</sub> = 151 nM, and DAT IC<sub>50</sub> > 100 000 nM at cloned human transporters (see ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Neil+Vaishnavi+et+al.+reported+NET+IC50+%3D+68+nM%2C+SERT+IC50+%3D+151+nM%2C+and+DAT+IC50+%3E+100%E2%80%89000+nM+at+cloned+human+transporters+%28see+ref+8%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Roggen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbol, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, T.</span><span> </span><span class="NLM_article-title">Synthesis of enantiomerically pure milnacipran analogs and inhibition of dopamine, serotonin, and norepinephrine transporters</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2834</span><span class="NLM_x">–</span> <span class="NLM_lpage">2837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2834-2837&author=H.+Roggenauthor=J.+Kehlerauthor=T.+B.+Stensbolauthor=T.+Hansen&title=Synthesis+of+enantiomerically+pure+milnacipran+analogs+and+inhibition+of+dopamine%2C+serotonin%2C+and+norepinephrine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoggen%26aufirst%3DH.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DStensbol%26aufirst%3DT.%2BB.%26aulast%3DHansen%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520enantiomerically%2520pure%2520milnacipran%2520analogs%2520and%2520inhibition%2520of%2520dopamine%252C%2520serotonin%252C%2520and%2520norepinephrine%2520transporters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2834%26epage%3D2837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tamiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Identification of 1<i>S</i>,2<i>R</i>-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3328</span><span class="NLM_x">–</span> <span class="NLM_lpage">3332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3328-3332&author=J.+Tamiyaauthor=B.+Dyckauthor=M.+Zhangauthor=K.+Phanauthor=B.+A.+Fleckauthor=A.+Aparicioauthor=F.+Jovicauthor=T.+Vickersauthor=J.+Greyauthor=A.+C.+Fosterauthor=C.+Chen&title=Identification+of+1S%2C2R-milnacipran+analogs+as+potent+norepinephrine+and+serotonin+transporter+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamiya%26aufirst%3DJ.%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DAparicio%26aufirst%3DA.%26aulast%3DJovic%26aufirst%3DF.%26aulast%3DVickers%26aufirst%3DT.%26aulast%3DGrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DIdentification%2520of%25201S%252C2R-milnacipran%2520analogs%2520as%2520potent%2520norepinephrine%2520and%2520serotonin%2520transporter%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3328%26epage%3D3332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Bonnaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couzinier, J. P.</span><span> </span><span class="NLM_article-title">1-Aryl-2-(aminomethyl)cyclopropanecarboxylic acid derivatives. A new series of potential antidepressants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00385a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=318-325&author=B.+Bonnaudauthor=H.+Cousseauthor=G.+Mouzinauthor=M.+Brileyauthor=A.+Stengerauthor=F.+Fauranauthor=J.+P.+Couzinier&title=1-Aryl-2-%28aminomethyl%29cyclopropanecarboxylic+acid+derivatives.+A+new+series+of+potential+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm00385a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00385a013%26sid%3Dliteratum%253Aachs%26aulast%3DBonnaud%26aufirst%3DB.%26aulast%3DCousse%26aufirst%3DH.%26aulast%3DMouzin%26aufirst%3DG.%26aulast%3DBriley%26aufirst%3DM.%26aulast%3DStenger%26aufirst%3DA.%26aulast%3DFauran%26aufirst%3DF.%26aulast%3DCouzinier%26aufirst%3DJ.%2BP.%26atitle%3D1-Aryl-2-%2528aminomethyl%2529cyclopropanecarboxylic%2520acid%2520derivatives.%2520A%2520new%2520series%2520of%2520potential%2520antidepressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D318%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesleh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1346-1349&author=C.+Chenauthor=B.+Dyckauthor=B.+A.+Fleckauthor=A.+C.+Fosterauthor=J.+Greyauthor=F.+Jovicauthor=M.+Meslehauthor=K.+Phanauthor=J.+Tamiyaauthor=T.+Vickersauthor=M.+Zhang&title=Studies+on+the+SAR+and+pharmacophore+of+milnacipran+derivatives+as+monoamine+transporter+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DGrey%26aufirst%3DJ.%26aulast%3DJovic%26aufirst%3DF.%26aulast%3DMesleh%26aufirst%3DM.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DTamiya%26aufirst%3DJ.%26aulast%3DVickers%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DStudies%2520on%2520the%2520SAR%2520and%2520pharmacophore%2520of%2520milnacipran%2520derivatives%2520as%2520monoamine%2520transporter%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1346%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Vickers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3230</span><span class="NLM_x">–</span> <span class="NLM_lpage">3235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3230-3235&author=T.+Vickersauthor=B.+Dyckauthor=J.+Tamiyaauthor=M.+Zhangauthor=F.+Jovicauthor=J.+Greyauthor=B.+A.+Fleckauthor=A.+Aparicioauthor=M.+Johnsauthor=L.+Jinauthor=H.+Tangauthor=A.+C.+Fosterauthor=C.+Chen&title=Studies+on+a+series+of+milnacipran+analogs+containing+a+heteroaromatic+group+as+potent+norepinephrine+and+serotonin+transporter+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DT.%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DTamiya%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJovic%26aufirst%3DF.%26aulast%3DGrey%26aufirst%3DJ.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DAparicio%26aufirst%3DA.%26aulast%3DJohns%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520milnacipran%2520analogs%2520containing%2520a%2520heteroaromatic%2520group%2520as%2520potent%2520norepinephrine%2520and%2520serotonin%2520transporter%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3230%26epage%3D3235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Shuto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span> </span><span class="NLM_article-title">(+/−)-(<i>Z</i>)-2-(Aminomethyl)-1-phenylcyclopropanecarboxamide derivatives as a new prototype of NMDA receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2968</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00015a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2964-2968&author=S.+Shutoauthor=H.+Takadaauthor=D.+Mochizukiauthor=R.+Tsujitaauthor=Y.+Haseauthor=S.+Onoauthor=N.+Shibuyaauthor=A.+Matsuda&title=%28%2B%2F%E2%88%92%29-%28Z%29-2-%28Aminomethyl%29-1-phenylcyclopropanecarboxamide+derivatives+as+a+new+prototype+of+NMDA+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00015a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00015a019%26sid%3Dliteratum%253Aachs%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26aulast%3DMochizuki%26aufirst%3DD.%26aulast%3DTsujita%26aufirst%3DR.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DShibuya%26aufirst%3DN.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3D%2528%252B%252F%25E2%2588%2592%2529-%2528Z%2529-2-%2528Aminomethyl%2529-1-phenylcyclopropanecarboxamide%2520derivatives%2520as%2520a%2520new%2520prototype%2520of%2520NMDA%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2964%26epage%3D2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><div class="note"><p class="first last">Also, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Also%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22a"><span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karady, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D.</span><span> </span><span class="NLM_article-title">Stereocontrolled synthesis of trisubstituted cyclopropanes: expedient, atom-economical, asymmetric syntheses of (+)-Bicifadine and DOV21947</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3885</span><span class="NLM_x">–</span> <span class="NLM_lpage">3888</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol061650w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=3885-3888&author=F.+Xuauthor=J.+A.+Murryauthor=B.+Simmonsauthor=E.+Corleyauthor=K.+Fitchauthor=S.+Karadyauthor=D.+Tschaen&title=Stereocontrolled+synthesis+of+trisubstituted+cyclopropanes%3A+expedient%2C+atom-economical%2C+asymmetric+syntheses+of+%28%2B%29-Bicifadine+and+DOV21947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fol061650w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol061650w%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DMurry%26aufirst%3DJ.%2BA.%26aulast%3DSimmons%26aufirst%3DB.%26aulast%3DCorley%26aufirst%3DE.%26aulast%3DFitch%26aufirst%3DK.%26aulast%3DKarady%26aufirst%3DS.%26aulast%3DTschaen%26aufirst%3DD.%26atitle%3DStereocontrolled%2520synthesis%2520of%2520trisubstituted%2520cyclopropanes%253A%2520expedient%252C%2520atom-economical%252C%2520asymmetric%2520syntheses%2520of%2520%2528%252B%2529-Bicifadine%2520and%2520DOV21947%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D3885%26epage%3D3888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Owens, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plott, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=9400006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK1cXis1GmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1305-1322&author=M.+J.+Owensauthor=W.+N.+Morganauthor=S.+J.+Plottauthor=C.+B.+Nemeroff&title=Neurotransmitter+receptor+and+transporter+binding+profile+of+antidepressants+and+their+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites</span></div><div class="casAuthors">Owens, Michael J.; Morgan, W. Neal; Plott, Susan J.; Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1305-1322</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Several new antidepressants that inhibit the serotonin (SERT) and norepinephrine transporters (NET) have been introduced into clin. practice the past several years.  This report focuses on the further pharmacol. characterization of nefazodone and its metabolites within the serotonergic and noradrenergic systems, in comparison with other antidepressants.  By use of radioligand binding assays, we measured the affinity (Ki) of 13 antidepressants and 6 metabolites for the rat and human SERT and NET.  The Ki values for eight of the antidepressants and three metabolites were also detd. for the rat 5-HT1A, 5-HT2A and muscarinic cholinergic receptors, the guinea pig histamine1 receptor and the human alpha-1 and alpha-2 receptors.  These data are useful for predicting side effect profiles and the potential for pharmacodynamic drug-drug interactions of antidepressants.  Of particular interest were the findings that paroxetine, generally thought of as a selective SERT antagonist, possesses moderately high affinity for the NET and that venlafaxine, which has been described as a "dual uptake inhibitor", possesses weak affinity for the NET.  We obsd. significant correlations in SERT (r = 0.965) or NET (r = 0.983) affinity between rat and human transporters.  Significant correlations were also obsd. between muscarinic cholinergic and NET affinity.  There are several significant correlations between affinities for the 5-HT1A, 5-HT2A, histamine1, alpha-1 and alpha-2 receptors.  These novel findings, not widely described previously, suggest that many of the, individual drugs studied in these expts. possess some structural characteristic that dets. affinity for several G protein-coupled, but not muscarinic, receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradn8u7KxbQrVg90H21EOLACvtfcHk0lh0PCDJaaH1MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1GmtQ%253D%253D&md5=fa8d12aed5de3875493c77cd9a869933</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DM.%2BJ.%26aulast%3DMorgan%26aufirst%3DW.%2BN.%26aulast%3DPlott%26aufirst%3DS.%2BJ.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DNeurotransmitter%2520receptor%2520and%2520transporter%2520binding%2520profile%2520of%2520antidepressants%2520and%2520their%2520metabolites%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1305%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinçon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouretti, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of milnacipran in liver impairment</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVeisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=273-279&author=C.+Puozzoauthor=H.+Albinauthor=G.+Vin%C3%A7onauthor=D.+Deprezauthor=J.+M.+Raymondauthor=M.+Amouretti&title=Pharmacokinetics+of+milnacipran+in+liver+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of milnacipran in liver impairment</span></div><div class="casAuthors">Puozzo, C.; Albin, H.; Vincon, G.; Deprez, D.; Raymond, J. M.; Amouretti, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-279</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Medecine et Hygiene</span>)
        </div><div class="casAbstract">The pharmacokinetics of single 50 mg oral and i.v. doses of milnacipran, a new non-tricyclic antidepressant drug, were compared in 11 chronic liver impaired (LI) subjects and in 6 control subjects.  Hepatic impairments, classified according to the PUGH scale were moderate (1 grade A), intermediate (6 grade B) and severe (4 grade C).  Concns. of unchanged drug and its conjugated form (its main metabolite) were measured in plasma and urines.  In control subjects, milnacipran present high abs. bioavailability (mean value of 90%).  Around 50% of the dose are excreted in urines as unchanged, while ≈14% are excreted as glucuroconjugate.  The remaining is composed of free and conjugated phase I inactive metabolites.  Administration of milnacipran in LI subjects results in non-significant changes in its pharmacokinetics, although its variability is increased.  Unchanged drug exposure is not modified in LI subjects, while plasma levels of the conjugate are slightly decreased compared to the control group.  This could either be due to a slight redn. in the conjugation process, or to a change in the distribution of the drug as urine excretion of both unchanged and conjugated forms are not modified compared to the control group.  A few LI subjects present supra-bioavailability resulting in higher drug exposure after oral administration than after i.v. infusion.  These modifications are not clin. relevant as drug exposure of the parent drug is not modified.  As the unchanged drug is the only compd. responsible for the activity of milnacipran, no dosage adjustment is needed in patients presenting liver impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcrlLSav0IYbVg90H21EOLACvtfcHk0lh0PCDJaaH1MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVeisbk%253D&md5=79ffb2eb99672b7e060e9c9a5b6a78da</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DAlbin%26aufirst%3DH.%26aulast%3DVin%25C3%25A7on%26aufirst%3DG.%26aulast%3DDeprez%26aufirst%3DD.%26aulast%3DRaymond%26aufirst%3DJ.%2BM.%26aulast%3DAmouretti%26aufirst%3DM.%26atitle%3DPharmacokinetics%2520of%2520milnacipran%2520in%2520liver%2520impairment%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1998%26volume%3D23%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozet, N</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baille, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zech, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of milnacipran in renal impairment</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVeisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=280-286&author=C.+Puozzoauthor=N+Pozetauthor=D.+Deprezauthor=P.+Bailleauthor=H.+L.+Ungauthor=P.+Zech&title=Pharmacokinetics+of+milnacipran+in+renal+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of milnacipran in renal impairment</span></div><div class="casAuthors">Puozzo, C.; Pozet, N.; Deprez, D.; Baille, P.; Ung, H. L.; Zech, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">280-286</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Medecine et Hygiene</span>)
        </div><div class="casAbstract">The pharmacokinetics of a single 50 mg dose of milnacipran, a new non-tricyclic antidepressant drug, were compared in 8 chronic renal failure subjects (Clcreat between 9-84.5 mL min-1) and in 6 healthy volunteers.  Concns. of unchanged (F2207 racemate and F2695 and F2696, enantiomers) and glucuroconjugated drug (main metabolite) were measured using HPLC and GC-MS.  As for drugs mainly eliminated via renal route, the pharmacokinetics of milnacipran were markedly affected by impaired renal function with the elimination half-life of severely impaired subject being ≈3 times that of the control group.  Milnacipran apparent total clearance and renal clearance were pos. correlated with glomerular filtration rate, while non-renal clearance and apparent vol. of distribution were unaffected by renal impairment.  Plasma concns. of the glucuroconjugate were gradually increased in plasma, while its total urine excretion remained unchanged.  As for the racemate, pharmacokinetics of each enantiomer were modified by renal failure, although, as predictable from its higher renal clearance value, it was more marked for F2696 than for F2695.  Considering that modifications were shown to be proportional to the degree of renal impairment and that milnacipran presents low variability, the necessary dose adjustment is therefore easy to predict.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb9PemW1HhirVg90H21EOLACvtfcHk0lgrZnbfIS0pgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVeisbY%253D&md5=18a20c7d56f5fb53b657774929f1aa7e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DPozet%26aufirst%3DN%26aulast%3DDeprez%26aufirst%3DD.%26aulast%3DBaille%26aufirst%3DP.%26aulast%3DUng%26aufirst%3DH.%2BL.%26aulast%3DZech%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520of%2520milnacipran%2520in%2520renal%2520impairment%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1998%26volume%3D23%26spage%3D280%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0lgrZnbfIS0pgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mattiuz, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponsler, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbuch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shugert, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J. M.</span><span> </span><span class="NLM_article-title">Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1124%2Fdmd.31.1.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=12485957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=88-97&author=E.+L.+Mattiuzauthor=G.+D.+Ponslerauthor=R.+J.+Barbuchauthor=P.+G.+Woodauthor=J.+H.+Mullenauthor=R.+L.+Shugertauthor=Q.+Liauthor=W.+J.+Wheelerauthor=F.+Kuoauthor=P.+C.+Conradauthor=J.+M.+Sauer&title=Disposition+and+metabolic+fate+of+atomoxetine+hydrochloride%3A+pharmacokinetics%2C+metabolism%2C+and+excretion+in+the+Fischer+344+rat+and+beagle+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog</span></div><div class="casAuthors">Mattiuz, Edward L.; Ponsler, G. Douglas; Barbuch, Robert J.; Wood, Paul G.; Mullen, John H.; Shugert, Richard L.; Li, Qimin; Wheeler, William J.; Kuo, Fengjiun; Conrad, Preston C.; Sauer, John-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-97</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">These studies were designed to characterize the disposition and metab. of atomoxetine hydrochloride [(-)-N-methyl-γ-(2-methylphenoxy)benzenepropanamine hydrochloride; formerly know as tomoxetine hydrochloride] in Fischer 344 rats and beagle dogs.  Atomoxetine was well absorbed from the gastrointestinal tract and cleared primarily by metab. with the majority of its metabolites being excreted into the urine, 66% of the total dose in the rat and 48% in the dog.  Fecal excretion, 32% of the total dose in the rat and 42% in the dog, appears to be due to biliary elimination and not due to unabsorbed dose.  Nearly the entire dose was excreted within 24 h in both species.  In the rat, low oral bioavailability was obsd. (F = 4%) compared with the high oral bioavailability in dog (F = 74%).  These differences appear to be almost purely mediated by the efficient first-pass hepatic clearance of atomoxetine in rat.  The biotransformation of atomoxetine was similar in the rat and dog, undergoing arom. ring hydroxylation, benzylic oxidn. (rat only), and N-demethylation.  The primary oxidative metabolite of atomoxetine was 4-hydroxyatomoxetine, which was subsequently conjugated forming O-glucuronide and O-sulfate (dog only) metabolites.  Although subtle differences were obsd. in the excretion and biotransformation of atomoxetine in rats and dogs, the primary difference obsd. between these species was the extent of first-pass metab. and the degree of systemic exposure to atomoxetine and its metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJhLRs_9WiNLVg90H21EOLACvtfcHk0lgrZnbfIS0pgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtV2mtA%253D%253D&md5=dab2a419ce1b74460be217a3ee195c64</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.1.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.1.88%26sid%3Dliteratum%253Aachs%26aulast%3DMattiuz%26aufirst%3DE.%2BL.%26aulast%3DPonsler%26aufirst%3DG.%2BD.%26aulast%3DBarbuch%26aufirst%3DR.%2BJ.%26aulast%3DWood%26aufirst%3DP.%2BG.%26aulast%3DMullen%26aufirst%3DJ.%2BH.%26aulast%3DShugert%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DKuo%26aufirst%3DF.%26aulast%3DConrad%26aufirst%3DP.%2BC.%26aulast%3DSauer%26aufirst%3DJ.%2BM.%26atitle%3DDisposition%2520and%2520metabolic%2520fate%2520of%2520atomoxetine%2520hydrochloride%253A%2520pharmacokinetics%252C%2520metabolism%252C%2520and%2520excretion%2520in%2520the%2520Fischer%2520344%2520rat%2520and%2520beagle%2520dog%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Descending control of pain</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1016%2FS0301-0082%2802%2900009-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=12034378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2002&pages=355-474&author=M.+J.+Millan&title=Descending+control+of+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Descending control of pain</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-474</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Upon receipt in the dorsal horn (DH) of the spinal cord, nociceptive (pain-signalling) information from the viscera, skin and other organs is subject to extensive processing by a diversity of mechanisms, certain of which enhance, and certain of which inhibit, its transfer to higher centers.  In this regard, a network of descending pathways projecting from cerebral structures to the DH plays a complex and crucial role.  Specific centrifugal pathways either suppress (descending inhibition) or potentiate (descending facilitation) passage of nociceptive messages to the brain.  Engagement of descending inhibition by the opioid analgesic, morphine, fulfils an important role in its pain-relieving properties, while induction of analgesia by the adrenergic agonist, clonidine, reflects actions at α2-adrenoceptors (α2-ARs) in the DH normally recruited by descending pathways.  However, opioids and adrenergic agents exploit but a tiny fraction of the vast panoply of mechanisms now known to be involved in the induction and/or expression of descending controls.  For example, no drug interfering with descending facilitation is currently available for clin. use.  The present review focuses on: (1) the organization of descending pathways and their pathophysiol. significance; (2) the role of individual transmitters and specific receptor types in the modulation and expression of mechanisms of descending inhibition and facilitation and (3) the advantages and limitations of established and innovative analgesic strategies which act by manipulation of descending controls.  Knowledge of descending pathways has increased exponentially in recent years, so this is an opportune moment to survey their operation and therapeutic relevance to the improved management of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgzpGfk_Zv97Vg90H21EOLACvtfcHk0lgrZnbfIS0pgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D&md5=9826f6eb6f47fb3e9d663adf496f5456</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2802%2900009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252802%252900009-6%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDescending%2520control%2520of%2520pain%26jtitle%3DProg.%2520Neurobiol.%26date%3D2002%26volume%3D66%26spage%3D355%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubner, R.</span><span> </span><span class="NLM_article-title">Descending modulation in persistent pain: an update</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=1-6&author=K.+Renauthor=R.+Dubner&title=Descending+modulation+in+persistent+pain%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DK.%26aulast%3DDubner%26aufirst%3DR.%26atitle%3DDescending%2520modulation%2520in%2520persistent%2520pain%253A%2520an%2520update%26jtitle%3DPain%26date%3D2002%26volume%3D100%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rygh, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A. H.</span><span> </span><span class="NLM_article-title">Bad news from the brain: descending 5-HT pathways that control spinal pain processing</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=613-617&author=R.+Suzukiauthor=L.+J.+Ryghauthor=A.+H.+Dickenson&title=Bad+news+from+the+brain%3A+descending+5-HT+pathways+that+control+spinal+pain+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DRygh%26aufirst%3DL.%2BJ.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26atitle%3DBad%2520news%2520from%2520the%2520brain%253A%2520descending%25205-HT%2520pathways%2520that%2520control%2520spinal%2520pain%2520processing%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D613%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhart, G. F.</span><span> </span><span class="NLM_article-title">Spinal serotonin receptors mediate descending facilitation of a nociceptiive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">550</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1016%2F0006-8993%2891%2990402-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=1888999" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=1991&pages=35-48&author=M.+Zhouauthor=G.+F.+Gebhart&title=Spinal+serotonin+receptors+mediate+descending+facilitation+of+a+nociceptiive+reflex+from+the+nuclei+reticularis+gigantocellularis+and+gigantocellularis+pars+alpha+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990402-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990402-H%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DGebhart%26aufirst%3DG.%2BF.%26atitle%3DSpinal%2520serotonin%2520receptors%2520mediate%2520descending%2520facilitation%2520of%2520a%2520nociceptiive%2520reflex%2520from%2520the%2520nuclei%2520reticularis%2520gigantocellularis%2520and%2520gigantocellularis%2520pars%2520alpha%2520in%2520the%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D550%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Yaksh, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCumber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkmus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaksh, M. C.</span><span> </span><span class="NLM_article-title">An automated flinch detecting system for use in the formalin nociceptive bioassay</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2386</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=2386-2402&author=T.+L.+Yakshauthor=G.+Ozakiauthor=D.+McCumberauthor=M.+Rathbunauthor=C.+Svenssonauthor=S.+Malkmusauthor=M.+C.+Yaksh&title=An+automated+flinch+detecting+system+for+use+in+the+formalin+nociceptive+bioassay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26aulast%3DOzaki%26aufirst%3DG.%26aulast%3DMcCumber%26aufirst%3DD.%26aulast%3DRathbun%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DC.%26aulast%3DMalkmus%26aufirst%3DS.%26aulast%3DYaksh%26aufirst%3DM.%2BC.%26atitle%3DAn%2520automated%2520flinch%2520detecting%2520system%2520for%2520use%2520in%2520the%2520formalin%2520nociceptive%2520bioassay%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D2001%26volume%3D90%26spage%3D2386%26epage%3D2402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. M.</span><span> </span><span class="NLM_article-title">An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1016%2F0304-3959%2892%2990041-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=1333581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslShtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1992&pages=355-363&author=S.+H.+Kimauthor=J.+M.+Chung&title=An+experimental+model+for+peripheral+neuropathy+produced+by+segmental+spinal+nerve+ligation+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat</span></div><div class="casAuthors">Kim S H; Chung J M</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-63</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">We attempted to develop an experimental animal model for peripheral neuropathic pain.  Under sodium pentobarbital anesthesia, both the L5 and L6 spinal nerves (group 1) or the L5 spinal nerve alone (group 2) of one side of the rat were tightly ligated.  For comparison, a parallel study was conducted with another group of rats (group 3) which received a partial tight sciatic nerve ligation, a paradigm developed previously as a neuropathy model.  Withdrawal latencies to application of radiant heat to the foot were tested for the next 16 weeks in all 3 groups.  Sensitivity of the hind paw to mechanical stimulation was tested with von Frey filaments.  The general behavior of each rat was noted during the entire test period.  Results suggested that the surgical procedure in all 3 groups produced a long-lasting hyperalgesia to noxious heat (at least 5 weeks) and mechanical allodynia (at least 10 weeks) of the affected foot.  In addition, there were behavioral signs of the presence of spontaneous pain in the affected foot.  Therefore, we believe we have developed an experimental animal model for peripheral neuropathy using tight ligations of spinal nerves.  The model manifests the symptoms of human patients with causalgia and is compatible with a previously developed neuropathy model.  The present model has two unique features.  First, the surgical procedure is stereotyped.  Second, the levels of injured and intact spinal segments are completely separated, allowing independent experimental manipulations of the injured and intact spinal segments in future experiments to answer questions regarding mechanisms underlying causalgia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvtj_Vg2vObihfW6udTcc2eawDx__sn3bYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslShtw%253D%253D&md5=13917a9997b26f37cd039fa54ee7eb36</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990041-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990041-9%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26atitle%3DAn%2520experimental%2520model%2520for%2520peripheral%2520neuropathy%2520produced%2520by%2520segmental%2520spinal%2520nerve%2520ligation%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1992%26volume%3D50%26spage%3D355%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Koch, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faurot, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuirk, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span> </span><span class="NLM_article-title">Modulation of mechano-hyperalgesia by clinically effective analgesics in rats with a peripheral mononeuropathy</span> <span class="citation_source-journal">Analgesia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK28XlvFyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=157-164&author=B.+D.+Kochauthor=G.+F.+Faurotauthor=J.+R.+McGuirkauthor=D.+E.+Clarkeauthor=J.+C.+Hunter&title=Modulation+of+mechano-hyperalgesia+by+clinically+effective+analgesics+in+rats+with+a+peripheral+mononeuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of mechano-hyperalgesia by clinically effective analgesics in rats with a peripheral mononeuropathy</span></div><div class="casAuthors">Koch, Bruce D.; Faurot, George F.; McGuirk, Jennifer R.; Clarke, David E.; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Analgesia (Elmsford, New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">AALGEB</span>;
        ISSN:<span class="NLM_cas:issn">1071-569X</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">An important feature of pain syndromes assocd. with an injured peripheral nerve is excessive sensitivity to previously innocuous and noxious mech. stimuli.  Whereas the former (mech. allodynia) has been studied extensively in exptl. models of neuropathic pain, extremely limited data have been produced concerning the latter (mech. hyperalgesia).  This is due, in part, to the variability and imprecise nature of the traditional methods used to measure mech. hyperalgesia.  Recently, a more robust and reliable method for measuring mech. hyperalgesia has been described: the Tal and Bennett pin prick assay.  We have investigated the ability of this assay to predict clin. effectiveness by using three categories of drugs favored for the treatment of neuropathic pain.  The tricyclic antidepressants, amitriptyline and desipramine, and the local anesthetic mexiletine all produced dose-dependent antihyperalgesia, as did the μ-opiate, morphine.  In contrast, the nontricyclic antidepressant fluoxetine was ineffective at doses well above those reported to block the neuronal uptake of serotonin, a finding consistent with available clin. data.  Carbamazepine was active only at doses above those that are anticonvulsant.  In conclusion, the pin prick test is a robust and reproducible assay for exptl. mech. hyperalgesia and may be useful to predict the clin. efficacy of drugs intended for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYF8_LH9nA67Vg90H21EOLACvtfcHk0ljx4KjsZNK3sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFyhtLo%253D&md5=7f9d0e514c8d7ee9942bdc12f531d8c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%2BD.%26aulast%3DFaurot%26aufirst%3DG.%2BF.%26aulast%3DMcGuirk%26aufirst%3DJ.%2BR.%26aulast%3DClarke%26aufirst%3DD.%2BE.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DModulation%2520of%2520mechano-hyperalgesia%2520by%2520clinically%2520effective%2520analgesics%2520in%2520rats%2520with%2520a%2520peripheral%2520mononeuropathy%26jtitle%3DAnalgesia%26date%3D1996%26volume%3D2%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22','cit22a'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn  Ball</span>, <span class="hlFld-ContribAuthor ">François  Bouzom</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Scherrmann</span>, <span class="hlFld-ContribAuthor ">Bernard  Walther</span>, and <span class="hlFld-ContribAuthor ">Xavier  Declèves</span>  . </span><span class="cited-content_cbyCitation_article-title">A Physiologically Based Modeling Strategy during Preclinical CNS Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2014,</strong> <em>11 </em>
                                    (3)
                                     , 836-848. <a href="https://doi.org/10.1021/mp400533q" title="DOI URL">https://doi.org/10.1021/mp400533q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/mp400533q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fmp400533q%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DA%252BPhysiologically%252BBased%252BModeling%252BStrategy%252Bduring%252BPreclinical%252BCNS%252BDrug%252BDevelopment%26aulast%3DBall%26aufirst%3DKathryn%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D2014%26date%3D02092013%26date%3D21012014%26date%3D20012014%26date%3D29012014%26date%3D03032014%26date%3D21012014%26volume%3D11%26issue%3D3%26spage%3D836%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Li</span>, <span class="hlFld-ContribAuthor ">Bin-Feng  Li</span>, <span class="hlFld-ContribAuthor ">Jian-Ge  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Sun</span>, and <span class="hlFld-ContribAuthor ">Zhenming  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">A Practical Kilogram-Scale Process to a Milnacipran Analogue, N,N-Diallyl (1R, 2R)-2-(Aminomethyl)-1-(2-thienyl)cyclopropanecarboxamide. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2012,</strong> <em>16 </em>
                                    (12)
                                     , 2021-2024. <a href="https://doi.org/10.1021/op3001542" title="DOI URL">https://doi.org/10.1021/op3001542</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op3001542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop3001542%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DA%252BPractical%252BKilogram-Scale%252BProcess%252Bto%252Ba%252BMilnacipran%252BAnalogue%25252C%252BN%25252CN-Diallyl%252B%2525281R%25252C%252B2R%252529-2-%252528Aminomethyl%252529-1-%2525282-thienyl%252529cyclopropanecarboxamide%26aulast%3DLi%26aufirst%3DChen%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D11062012%26date%3D25092012%26date%3D21122012%26date%3D29082012%26volume%3D16%26issue%3D12%26spage%3D2021%26epage%3D2024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoffer  Bundgaard</span>, <span class="hlFld-ContribAuthor ">Elin  Eneberg</span>, <span class="hlFld-ContribAuthor ">Connie  Sánchez</span>. </span><span class="cited-content_cbyCitation_article-title">P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood–brain barrier in vivo. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2016,</strong> <em>103 </em>, 104-111. <a href="https://doi.org/10.1016/j.neuropharm.2015.12.009" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2015.12.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2015.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2015.12.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DP-glycoprotein%252Bdifferentially%252Baffects%252Bescitalopram%25252C%252Blevomilnacipran%25252C%252Bvilazodone%252Band%252Bvortioxetine%252Btransport%252Bat%252Bthe%252Bmouse%252Bblood%2525E2%252580%252593brain%252Bbarrier%252Bin%2525C2%2525A0vivo%26aulast%3DBundgaard%26aufirst%3DChristoffer%26date%3D2016%26volume%3D103%26spage%3D104%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuki  Ishizuka</span>, <span class="hlFld-ContribAuthor ">Hirohisa  Fujimori</span>, <span class="hlFld-ContribAuthor ">Takuya  Noguchi</span>, <span class="hlFld-ContribAuthor ">Masashi  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Mari  Kishida</span>, <span class="hlFld-ContribAuthor ">Takuya  Nagai</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Imai</span>, <span class="hlFld-ContribAuthor ">Masayuki  Kirihara</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Syntheses of Pharmaceuticals Containing a Cyclopropane Moiety Using Catalytic Asymmetric Simmons–Smith Reactions of Allylalcohols: Syntheses of Optically Active Tranylcypromine and Milnacipran. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Letters</span><span> <strong>2013,</strong> <em>42 </em>
                                    (10)
                                     , 1311-1313. <a href="https://doi.org/10.1246/cl.130498" title="DOI URL">https://doi.org/10.1246/cl.130498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/cl.130498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fcl.130498%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Letters%26atitle%3DAsymmetric%252BSyntheses%252Bof%252BPharmaceuticals%252BContaining%252Ba%252BCyclopropane%252BMoiety%252BUsing%252BCatalytic%252BAsymmetric%252BSimmons%2525E2%252580%252593Smith%252BReactions%252Bof%252BAllylalcohols%25253A%252BSyntheses%252Bof%252BOptically%252BActive%252BTranylcypromine%252Band%252BMilnacipran%26aulast%3DIshizuka%26aufirst%3DYuki%26date%3D2013%26volume%3D42%26issue%3D10%26spage%3D1311%26epage%3D1313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lori Jean  Van Orden</span>, <span class="hlFld-ContribAuthor ">Priscilla M.  Van Dyke</span>, <span class="hlFld-ContribAuthor ">D. Roland  Saito</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Church</span>, <span class="hlFld-ContribAuthor ">Ray  Chang</span>, <span class="hlFld-ContribAuthor ">Jacqueline A.M.  Smith</span>, <span class="hlFld-ContribAuthor ">William J.  Martin</span>, <span class="hlFld-ContribAuthor ">Sarah  Jaw-Tsai</span>, <span class="hlFld-ContribAuthor ">Eric L.  Stangeland</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: Synthesis and structure–activity relationships. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (5)
                                     , 1456-1461. <a href="https://doi.org/10.1016/j.bmcl.2012.12.061" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.12.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.12.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bnovel%252Bclass%252Bof%252B3-%252528phenoxy-phenyl-methyl%252529-pyrrolidines%252Bas%252Bpotent%252Band%252Bbalanced%252Bnorepinephrine%252Band%252Bserotonin%252Breuptake%252Binhibitors%25253A%252BSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%26aulast%3DVan%2BOrden%26aufirst%3DLori%2BJean%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D1456%26epage%3D1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Joel  Goldberg</span>, <span class="hlFld-ContribAuthor ">Casey C.  McComas</span>, <span class="hlFld-ContribAuthor ">Eugene J.  Trybulski</span>, <span class="hlFld-ContribAuthor ">Richard P.  Woodworth</span>, <span class="hlFld-ContribAuthor ">Darlene C.  Deecher</span>, <span class="hlFld-ContribAuthor ">Garth T.  Whiteside</span>, <span class="hlFld-ContribAuthor ">Puwen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (5)
                                     , 1555-1558. <a href="https://doi.org/10.1016/j.bmcl.2010.01.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnorepinephrine%252Breuptake%252Binhibitors%252Bwith%252Bbenzothiadiazine%252Bdioxide%252Bor%252Bdihydrosulfostyril%252Bcores%26aulast%3DFensome%26aufirst%3DAndrew%26date%3D2010%26volume%3D20%26issue%3D5%26spage%3D1555%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob  Andersen</span>, <span class="hlFld-ContribAuthor ">Anders S.  Kristensen</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Kristian  Strømgaard</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2009,</strong> <em>30 </em>
                                    (25)
                                     , 3677. <a href="https://doi.org/10.1039/b903035m" title="DOI URL">https://doi.org/10.1039/b903035m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b903035m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb903035m%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bunderstanding%252Bof%252Bthe%252Binteraction%252Bof%252Bantidepressant%252Bdrugs%252Bwith%252Bserotonin%252Band%252Bnorepinephrine%252Btransporters%26aulast%3DAndersen%26aufirst%3DJacob%26date%3D2009%26volume%3D30%26issue%3D25%26spage%3D3677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of milnacipran (<b>1</b>) and its analogues atomoxetine (<b>6</b>) and duloxetine (<b>7</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0006.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (i) NaHMDS, THF, 0 °C; (ii) (<i>R</i>)-(−)-epichlorohydrin, 0 °C to room temp, 16 h; (iii) KOH, EtOH, reflux, 8 h; (iv) 12 N HCl, 0 °C to room temp, 2.5 h; (b) (i) potassium phthalamide, DMF, 120 °C, 16 h; (c) (COCl)<sub>2</sub>, MeOH, room temp, 2 h; (d) (i) SOCl<sub>2</sub>; (ii) R<sup>1</sup>R<sup>2</sup>NH, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to room temp, 16 h; (iii) MeNHNH<sub>2</sub>, EtOH, room temp, 16 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds 2<i>R</i>-<b>1</b>, <b>4</b>, <b>5b</b>,<b>5c</b>, <b>5f</b>, and <b>5h</b> in rat formalin test (phase IIA) after 60 mg/kg oral administration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose−response of compound <b>5c</b> in rat formalin test (phase IIA) in comparison with 2<i>R</i>-<b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/medium/jm-2008-009537_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Dose-dependent reversal of pin-prick-induced mechanical hyperalgesia by compounds <b>5c</b> and 2<i>R</i>-<b>1</b> in rat SNL model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-22/jm8009537/production/images/large/jm-2008-009537_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8009537&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65622" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65622" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Iversen, L.</span><span> </span><span class="NLM_article-title">Neurotransmitter transporters and their impact on the development of psychopharmacology</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x">, </span> <span class="NLM_fpage">S82</span><span class="NLM_x">–</span> <span class="NLM_lpage">S88</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=S82-S88&author=L.+Iversen&title=Neurotransmitter+transporters+and+their+impact+on+the+development+of+psychopharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIversen%26aufirst%3DL.%26atitle%3DNeurotransmitter%2520transporters%2520and%2520their%2520impact%2520on%2520the%2520development%2520of%2520psychopharmacology%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D147%26spage%3DS82%26epage%3DS88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Runyon, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, F. I.</span><span> </span><span class="NLM_article-title">Dopamine transporter ligands: recent developments and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1825</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.2174%2F156802606778249775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=17017960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1825-1843&author=S.+P.+Runyonauthor=F.+I.+Carroll&title=Dopamine+transporter+ligands%3A+recent+developments+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transporter ligands: recent developments and therapeutic potential</span></div><div class="casAuthors">Runyon, Scott P.; Carroll, F. Ivy</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1825-1843</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The dopamine transporter (DAT) is a target for the development of pharmacotherapies for a no. of central disorders including Parkinson's disease, Alzheimer's disease, schizophrenia, Tourette's syndrome, Lesch-Nyhan disease, attention deficit hyperactivity disorder (ADHD), obesity, depression, and stimulant abuse as well as normal aging.  Considerable effort continues to be devoted to the development of new ligands for the DAT.  In this review, we present some of the more interesting ligands developed during the last few years from the 3-phenytropane, 1,4-dialkylpiperazine, phenylpiperidine, and benztropine classes of DAT uptake inhibitors as well as a few less studied misc. DAT uptake inhibitors.  Studies related to the therapeutic potential of some of the more studied compds. are presented.  A few of the compds. have been studied as pharmacotherapies for Parkinson's disease, ADHD, and obesity.  However, most of the drug discovery studies have been directed toward pharmacotherapies for stimulant abuse (mainly cocaine).  A no. of the compds. showed decreased cocaine maintained responding in rhesus monkeys trained to self-administer cocaine.  One compd., GBR 12909, was evaluated in a Phase 1 clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtevTL8FZC3rVg90H21EOLACvtfcHk0lh6__L266Ue4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurjE&md5=972cacd0661e7394126d698da4407152</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F156802606778249775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249775%26sid%3Dliteratum%253Aachs%26aulast%3DRunyon%26aufirst%3DS.%2BP.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26atitle%3DDopamine%2520transporter%2520ligands%253A%2520recent%2520developments%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1825%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gibson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettinger, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crismon, M. L.</span><span> </span><span class="NLM_article-title">Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1134</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=1134-1142&author=A.+P.+Gibsonauthor=T.+L.+Bettingerauthor=N.+C.+Patelauthor=M.+L.+Crismon&title=Atomoxetine+versus+stimulants+for+treatment+of+attention+deficit%2Fhyperactivity+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DA.%2BP.%26aulast%3DBettinger%26aufirst%3DT.%2BL.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DCrismon%26aufirst%3DM.%2BL.%26atitle%3DAtomoxetine%2520versus%2520stimulants%2520for%2520treatment%2520of%2520attention%2520deficit%252Fhyperactivity%2520disorder%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2006%26volume%3D40%26spage%3D1134%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Frampton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plosker, G. L.</span><span> </span><span class="NLM_article-title">Duloxetine: a review of its use in the treatment of major depressive disorder</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=581-609&author=J.+E.+Framptonauthor=G.+L.+Plosker&title=Duloxetine%3A+a+review+of+its+use+in+the+treatment+of+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrampton%26aufirst%3DJ.%2BE.%26aulast%3DPlosker%26aufirst%3DG.%2BL.%26atitle%3DDuloxetine%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520the%2520treatment%2520of%2520major%2520depressive%2520disorder%26jtitle%3DCNS%2520Drugs%26date%3D2007%26volume%3D21%26spage%3D581%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Stahl, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grady, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span> </span><span class="NLM_article-title">SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants</span> <span class="citation_source-journal">CNS Spectrosc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">732</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=16142213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADC%252BD2MvntFGjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=732-347&author=S.+M.+Stahlauthor=M.+M.+Gradyauthor=C.+Moretauthor=M.+Briley&title=SNRIs%3A+their+pharmacology%2C+clinical+efficacy%2C+and+tolerability+in+comparison+with+other+classes+of+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants</span></div><div class="casAuthors">Stahl Stephen M; Grady Meghan M; Moret Chantal; Briley Mike</div><div class="citationInfo"><span class="NLM_cas:title">CNS spectrums</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">732-47</span>
        ISSN:<span class="NLM_cas:issn">1092-8529</span>.
    </div><div class="casAbstract">The class of serotonin and norepinephrine reuptake inhibitors (SNRIs) now comprises three medications: venlafaxine, milnacipran, and duloxetine.  These drugs block the reuptake of both serotonin (5-HT) and norepinephrine with differing selectivity.  Whereas milnacipran blocks 5-HT and norepinephrine reuptake with equal affinity, duloxetine has a 10-fold selectivity for 5-HT and venlafaxine a 30-fold selectivity for 5-HT.  All three SNRIs are efficacious in treating a variety of anxiety disorders.  There is no evidence for major differences between SNRIs and SSRIs in their efficacy in treating anxiety disorders.  In contrast to SSRIs, which are generally ineffective in treating chronic pain, all three SNRIs seem to be helpful in relieving chronic pain associated with and independent of depression.  Tolerability of an SNRI at therapeutic doses varies within the class.  Although no direct comparative data are available, venlafaxine seems to be the least well-tolerated, combining serotonergic adverse effects (nausea, sexual dysfunction, withdrawal problems) with a dose-dependent cardiovascular phenomenon, principally hypertension.  Duloxetine and milnacipran appear better tolerated and essentially devoid of cardiovascular toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_ihXu61xcczW1zwg2yUK5fW6udTcc2eZZZb2FFzNcArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvntFGjsQ%253D%253D&md5=b4a197b2730c0669c0a23dc7c75be4c7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26aulast%3DGrady%26aufirst%3DM.%2BM.%26aulast%3DMoret%26aufirst%3DC.%26aulast%3DBriley%26aufirst%3DM.%26atitle%3DSNRIs%253A%2520their%2520pharmacology%252C%2520clinical%2520efficacy%252C%2520and%2520tolerability%2520in%2520comparison%2520with%2520other%2520classes%2520of%2520antidepressants%26jtitle%3DCNS%2520Spectrosc.%26date%3D2005%26volume%3D10%26spage%3D732%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mochizucki, D.</span><span> </span><span class="NLM_article-title">Serotonin and noradrenaline reuptake inhibitors in animal models of pain</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">S15</span><span class="NLM_x">–</span> <span class="NLM_lpage">S19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=S15-S19&author=D.+Mochizucki&title=Serotonin+and+noradrenaline+reuptake+inhibitors+in+animal+models+of+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMochizucki%26aufirst%3DD.%26atitle%3DSerotonin%2520and%2520noradrenaline%2520reuptake%2520inhibitors%2520in%2520animal%2520models%2520of%2520pain%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2004%26volume%3D19%26spage%3DS15%26epage%3DS19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bisserbe, J. C.</span><span> </span><span class="NLM_article-title">Clinical utility of milnacipran in comparison with other antidepressants</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S43</span><span class="NLM_x">–</span> <span class="NLM_lpage">S50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=S43-S50&author=J.+C.+Bisserbe&title=Clinical+utility+of+milnacipran+in+comparison+with+other+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBisserbe%26aufirst%3DJ.%2BC.%26atitle%3DClinical%2520utility%2520of%2520milnacipran%2520in%2520comparison%2520with%2520other%2520antidepressants%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2002%26volume%3D17%26spage%3DS43%26epage%3DS50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Neil Vaishnavi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plott, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kranzler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, M. J.</span><span> </span><span class="NLM_article-title">Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=320-322&author=S.+Neil+Vaishnaviauthor=C.+B.+Nemeroffauthor=S.+J.+Plottauthor=S.+G.+Raoauthor=J.+Kranzlerauthor=M.+J.+Owens&title=Milnacipran%3A+a+comparative+analysis+of+human+monoamine+uptake+and+transporter+binding+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeil%2BVaishnavi%26aufirst%3DS.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26aulast%3DPlott%26aufirst%3DS.%2BJ.%26aulast%3DRao%26aufirst%3DS.%2BG.%26aulast%3DKranzler%26aufirst%3DJ.%26aulast%3DOwens%26aufirst%3DM.%2BJ.%26atitle%3DMilnacipran%253A%2520a%2520comparative%2520analysis%2520of%2520human%2520monoamine%2520uptake%2520and%2520transporter%2520binding%2520affinity%26jtitle%3DBiol.%2520Psychiatry%26date%3D2004%26volume%3D55%26spage%3D320%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Rooks, D. S.</span><span> </span><span class="NLM_article-title">Fibromyalgia treatment update</span> <span class="citation_source-journal">Curr. Opin. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FnvF2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=111-117&author=D.+S.+Rooks&title=Fibromyalgia+treatment+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Fibromyalgia treatment update</span></div><div class="casAuthors">Rooks Daniel S</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in rheumatology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-7</span>
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Fibromyalgia is a common chronic pain disorder characterized by complex symptomatology and few consistently effective treatments.  The purpose of this review is to highlight the recent literature from April 2005 through September 2006 involving treatment options.  RECENT FINDINGS:  Prior evidence suggests that medication and self-management approaches to care can improve symptoms, function and well-being in this patient population.  Recent studies examining the efficacy of two serotonin and norepinephrine-reuptake inhibitors--duloxetine and milnacipran--and the anticonvulsant pregabalin are encouraging.  Studies evaluating different forms of exercise continue to support the belief that increased physical activity is an essential component of any treatment plan for the patient with fibromyalgia.  Three studies added to the understanding of treatment adherence.  Finally, three studies evaluating the efficacy of acupuncture in the treatment of fibromyalgia showed conflicting results, but added to the knowledge needed for clinicians to have substantive conversations with patients.  SUMMARY:  Recent studies support the recommendation of a multimodal approach to treatment involving individualized, evidence-based pharmacotherapy and self-management.  Treatment goals should include the improvement of symptoms, primarily pain and sleep, and the promotion of positive health behaviors with the aim of improving physical function and emotional well-being.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7mZlo5bGGz9enUz0lpNqnfW6udTcc2eaHoQxXXsm7gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FnvF2jsw%253D%253D&md5=b2fc1b3635aba5f1d04db6d18761d71d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRooks%26aufirst%3DD.%2BS.%26atitle%3DFibromyalgia%2520treatment%2520update%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2007%26volume%3D19%26spage%3D111%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Leo, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, V. L.</span><span> </span><span class="NLM_article-title">Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsVagu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=637-642&author=R.+J.+Leoauthor=V.+L.+Brooks&title=Clinical+potential+of+milnacipran%2C+a+serotonin+and+norepinephrine+reuptake+inhibitor%2C+in+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain</span></div><div class="casAuthors">Leo, Raphael J.; Brooks, Victoria L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">637-642</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Milnacipran is a serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor currently available for use as an antidepressant in several countries.  Phase III clin. trials are currently underway to assess its potential role in the treatment of fibromyalgia syndrome, and in pursuit of US Food and Drug Administration approval for this indication.  Evidence has accumulated suggesting that in animal models, milnacipran may exert pain-mitigating influences involving NE- and 5-HT-related processes at supraspinal, spinal and peripheral levels of pain transmission.  Preliminary evidence suggests that milnacipran may be useful in mitigating pain and fatigue assocd. with fibromyalgia.  However, its role in addressing comorbidities assocd. with fibromyalgia, including visceral pain and migraine, has yet to be investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQhSpYMSSy_7Vg90H21EOLACvtfcHk0liKCvRIwo6y8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsVagu7Y%253D&md5=41865ee926e9d440b46eb5be0e919ab3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DR.%2BJ.%26aulast%3DBrooks%26aufirst%3DV.%2BL.%26atitle%3DClinical%2520potential%2520of%2520milnacipran%252C%2520a%2520serotonin%2520and%2520norepinephrine%2520reuptake%2520inhibitor%252C%2520in%2520pain%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2006%26volume%3D7%26spage%3D637%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><div class="note"><p class="first last">Calculated log <i>P</i> values were 1.2 for milnacipran and 3.3 for atomoxetine using ACD software.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Calculated+log%E2%80%89P+values+were+1.2+for+milnacipran+and+3.3+for+atomoxetine+using+ACD+software."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of milnacipran in comparison with other antidepressants</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADyaK2s%252FotFyrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1996&pages=15-27&issue=Suppl.+4&author=C.+Puozzoauthor=B.+E.+Leonard&title=Pharmacokinetics+of+milnacipran+in+comparison+with+other+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of milnacipran in comparison with other antidepressants</span></div><div class="casAuthors">Puozzo C; Leonard B E</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">11 Suppl 4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-27</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">Despite the large number of antidepressants currently available, it is still necessary to develop new drugs that combine the efficacy of the older antidepressant with improved safety, tolerability and therapeutic profile that will allow them to be used in depressed patients who are elderly or with cardiac, renal or hepatic disease.  This article reviews the pharmacokinetic characteristics of the tricyclic antidepressants, the selective serotonin reuptake inhibitors (SSRIs) and more recently introduced antidepressants such as venlafaxine and nefazodone.  Milnacipran (Ixel), a novel drug, combines antidepressant efficacy with some unique pharmacokinetic features.  A summary of its pharmacokinetic profile shows that milnacipran has a high bioavailability, low plasma protein binding and that it is largely eliminated in the urine as parent drug or as a glucuronide.  These features suggest that the likelihood of interactions with other drugs given concurrently is lower than would occur with most second generation antidepressants and the tricyclic antidepressants.  Furthermore, studies in patients with liver dysfunction, and in the elderly, suggest that dose adjustment is not necessary when milnacipran is administered to these patients.  The decrease in milnacipran elimination is correlated to the degree of renal impairment, allowing adjustment of schedules.  In comparison to earlier antidepressants, milnacipran combines efficacy and a relatively low side-effect profile with the added advantage of fewer interactions with drugs that may be given concurrently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMqDHTs6pfx_3jf77P2BG3fW6udTcc2eaHoQxXXsm7gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FotFyrsg%253D%253D&md5=4cdde68e6ed61298862f038901cbfd74</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DPharmacokinetics%2520of%2520milnacipran%2520in%2520comparison%2520with%2520other%2520antidepressants%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1996%26volume%3D11%26issue%3DSuppl.%25204%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panconi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span> </span><span class="NLM_article-title">Pharmacology and pharmacokinetics of milnacipran</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S25</span><span class="NLM_x">–</span> <span class="NLM_lpage">S35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=S25-S35&author=C.+Puozzoauthor=E.+Panconiauthor=D.+Deprez&title=Pharmacology+and+pharmacokinetics+of+milnacipran"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DPanconi%26aufirst%3DE.%26aulast%3DDeprez%26aufirst%3DD.%26atitle%3DPharmacology%2520and%2520pharmacokinetics%2520of%2520milnacipran%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2002%26volume%3D17%26spage%3DS25%26epage%3DS35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosillon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deroubaix, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span> </span><span class="NLM_article-title">Lack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressants</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFSktb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=977-988&author=C.+Puozzoauthor=S.+Lensauthor=C.+Rehauthor=K.+Michaelisauthor=D.+Rosillonauthor=X.+Deroubaixauthor=D.+Deprez&title=Lack+of+interaction+of+milnacipran+with+the+cytochrome+p450+isoenzymes+frequently+involved+in+the+metabolism+of+antidepressants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of interaction of milnacipran with the cytochrome P450 isoenzymes frequently involved in the metabolism of antidepressants</span></div><div class="casAuthors">Puozzo, Christian; Lens, Simone; Reh, Christian; Michaelis, Karl; Rosillon, Dominique; Deroubaix, Xavier; Deprez, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">977-988</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">To compare the pharmacokinetics of milnacipran in extensive metabolisers (EMs) and poor metabolisers (PMs) of sparteine and mephenytoin, and to assess the influence of multiple administrations of milnacipran on the activity of cytochrome P 450 (CYP) isoenzymes through its own metab. and through various probes, namely CYP2D6 (sparteine/dextromethorphan), CYP2C19 (mephenytoin), CYP1A2 (caffeine) and CYP3A4 (endogenous 6-β-hydroxy-cortisol excretion).  Twenty-five healthy subjects, 12 EMs for both sparteine/dextromethorphan and mephenytoin, nine EMs for mephenytoin and PMs for sparteine/dextromethorphan (PM2D6) and four PMs for mephenytoin and EMs for sparteine/dextromethorphan (PM2C19) were administered milnacipran as a single 50 mg capsule on day 1 followed by a 50 mg capsule twice daily for 7 days.  The pharmacokinetics of milnacipran and its oxidative metabolites were assessed after the first dose (day 1) and after multiple administration (day 8), and were compared for differences between CYP2D6 and CYP2C19 PMs and EMs.  Metabolic tests were performed before (day -2), during (days 1 and 8) and after (day 20) milnacipran administration.  Milnacipran steady state was rapidly achieved.  Metab. was limited: approx. 50% unchanged drug, 30% as glucuronide and 20% as oxidative metabolite (mainly F2800 the N-dealkyl metabolite).  Milnacipran administration to PM2D6 and PM2C19 subjects did not increase parent drug exposure or decrease metabolite exposure.  Milnacipran oxidative metab. is not mediated through CYP2D6 or CYP2C19 polymorphic pathways nor does it significantly interact with CYP1A2, CYP2C19, CYP2D6 or CYP3A4 activities.  Limited reciprocal pharmacokinetic interaction between milnacipran and CYP isoenzymes would confer flexibility in the therapeutic use of the drug when combined with antidepressants.  Drug-drug interaction risk would be low, even if the combined treatments were likely to inhibit CYP2D6 and CYP2C19 isoenzyme activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVvpa0a8FGrVg90H21EOLACvtfcHk0liKCvRIwo6y8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFSktb3J&md5=b7140b28e2079ca8c40dcb8e7abadeef</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DLens%26aufirst%3DS.%26aulast%3DReh%26aufirst%3DC.%26aulast%3DMichaelis%26aufirst%3DK.%26aulast%3DRosillon%26aufirst%3DD.%26aulast%3DDeroubaix%26aufirst%3DX.%26aulast%3DDeprez%26aufirst%3DD.%26atitle%3DLack%2520of%2520interaction%2520of%2520milnacipran%2520with%2520the%2520cytochrome%2520p450%2520isoenzymes%2520frequently%2520involved%2520in%2520the%2520metabolism%2520of%2520antidepressants%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2005%26volume%3D44%26spage%3D977%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Preskorn, S. H.</span><span> </span><span class="NLM_article-title">Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitor</span> <span class="citation_source-journal">J. Psychiatr. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1097%2F00131746-200403000-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=15330407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADC%252BD2cvisFWitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=119-126&author=S.+H.+Preskorn&title=Milnacipran%3A+a+dual+norepinephrine+and+serotonin+reuptake+pump+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitor</span></div><div class="casAuthors">Preskorn Sheldon H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric practice</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-26</span>
        ISSN:<span class="NLM_cas:issn">1527-4160</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe_m3nZG_f0f6AExegM5LLfW6udTcc2eb8TQPfJGsfJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvisFWitw%253D%253D&md5=737ed2988f90e4766d2f73bd72c1fed9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2F00131746-200403000-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00131746-200403000-00006%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%2BH.%26atitle%3DMilnacipran%253A%2520a%2520dual%2520norepinephrine%2520and%2520serotonin%2520reuptake%2520pump%2520inhibitor%26jtitle%3DJ.%2520Psychiatr.%2520Pract.%26date%3D2004%26volume%3D10%26spage%3D119%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><div class="note"><p class="first last">The following data were reported by Moret et al. for milnacipran inhibition of monoamine uptake in rat brain slice: NET IC<sub>50</sub> = 100 nM, SERT IC<sub>50</sub> = 203 nM (</p></div><span class="NLM_contrib-group">Moret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charveron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couzinier, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span> </span><span class="NLM_article-title">Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1219</span><div class="note"><p class="first last">)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1985&pages=1211-1219&author=C.+Moretauthor=M.+Charveronauthor=J.+P.+Finbergauthor=J.+P.+Couzinierauthor=M.+Briley&title=Biochemical+profile+of+midalcipran+%28F+2207%29%2C+1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane+%28Z%29+hydrochloride%2C+a+potential+fourth+generation+antidepressant+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoret%26aufirst%3DC.%26aulast%3DCharveron%26aufirst%3DM.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26aulast%3DCouzinier%26aufirst%3DJ.%2BP.%26aulast%3DBriley%26aufirst%3DM.%26atitle%3DBiochemical%2520profile%2520of%2520midalcipran%2520%2528F%25202207%2529%252C%25201-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane%2520%2528Z%2529%2520hydrochloride%252C%2520a%2520potential%2520fourth%2520generation%2520antidepressant%2520drug%26jtitle%3DNeuropharmacology%26date%3D1985%26volume%3D24%26spage%3D1211%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><div class="note"><p class="first last">Mochizuki et al. reported the following values at rat synaptosomes: NET IC<sub>50</sub> = 29.6 nM, SERT IC<sub>50</sub> = 28 nM; DAT IC<sub>50</sub> > 10 000 nM (</p></div><span class="NLM_contrib-group">Mochizuki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, N.</span><span> </span><span class="NLM_article-title">Neurochemical and behavioural characterization of milnacipran, a serotonin and norepinephrine reuptake inhibitor in rats</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">162</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><div class="note"><p class="first last">)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2002&pages=323-332&author=D.+Mochizukiauthor=R.+Tsujitaauthor=S.+Yamadaauthor=K.+Kawasakiauthor=Y.+Otsukaauthor=S.+Hashimotoauthor=T.+Hattoriauthor=Y.+Kitamuraauthor=N.+Miki&title=Neurochemical+and+behavioural+characterization+of+milnacipran%2C+a+serotonin+and+norepinephrine+reuptake+inhibitor+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMochizuki%26aufirst%3DD.%26aulast%3DTsujita%26aufirst%3DR.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKawasaki%26aufirst%3DK.%26aulast%3DOtsuka%26aufirst%3DY.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DMiki%26aufirst%3DN.%26atitle%3DNeurochemical%2520and%2520behavioural%2520characterization%2520of%2520milnacipran%252C%2520a%2520serotonin%2520and%2520norepinephrine%2520reuptake%2520inhibitor%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2002%26volume%3D162%26spage%3D323%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><div class="note"><p class="first last">Neil Vaishnavi et al. reported NET IC<sub>50</sub> = 68 nM, SERT IC<sub>50</sub> = 151 nM, and DAT IC<sub>50</sub> > 100 000 nM at cloned human transporters (see ref <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a>).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Neil+Vaishnavi+et+al.+reported+NET+IC50+%3D+68+nM%2C+SERT+IC50+%3D+151+nM%2C+and+DAT+IC50+%3E+100%E2%80%89000+nM+at+cloned+human+transporters+%28see+ref+8%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Roggen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbol, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, T.</span><span> </span><span class="NLM_article-title">Synthesis of enantiomerically pure milnacipran analogs and inhibition of dopamine, serotonin, and norepinephrine transporters</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2834</span><span class="NLM_x">–</span> <span class="NLM_lpage">2837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2834-2837&author=H.+Roggenauthor=J.+Kehlerauthor=T.+B.+Stensbolauthor=T.+Hansen&title=Synthesis+of+enantiomerically+pure+milnacipran+analogs+and+inhibition+of+dopamine%2C+serotonin%2C+and+norepinephrine+transporters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoggen%26aufirst%3DH.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DStensbol%26aufirst%3DT.%2BB.%26aulast%3DHansen%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520enantiomerically%2520pure%2520milnacipran%2520analogs%2520and%2520inhibition%2520of%2520dopamine%252C%2520serotonin%252C%2520and%2520norepinephrine%2520transporters%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2834%26epage%3D2837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tamiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Identification of 1<i>S</i>,2<i>R</i>-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3328</span><span class="NLM_x">–</span> <span class="NLM_lpage">3332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3328-3332&author=J.+Tamiyaauthor=B.+Dyckauthor=M.+Zhangauthor=K.+Phanauthor=B.+A.+Fleckauthor=A.+Aparicioauthor=F.+Jovicauthor=T.+Vickersauthor=J.+Greyauthor=A.+C.+Fosterauthor=C.+Chen&title=Identification+of+1S%2C2R-milnacipran+analogs+as+potent+norepinephrine+and+serotonin+transporter+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamiya%26aufirst%3DJ.%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DAparicio%26aufirst%3DA.%26aulast%3DJovic%26aufirst%3DF.%26aulast%3DVickers%26aufirst%3DT.%26aulast%3DGrey%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DIdentification%2520of%25201S%252C2R-milnacipran%2520analogs%2520as%2520potent%2520norepinephrine%2520and%2520serotonin%2520transporter%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3328%26epage%3D3332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Bonnaud, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousse, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauran, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couzinier, J. P.</span><span> </span><span class="NLM_article-title">1-Aryl-2-(aminomethyl)cyclopropanecarboxylic acid derivatives. A new series of potential antidepressants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00385a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=318-325&author=B.+Bonnaudauthor=H.+Cousseauthor=G.+Mouzinauthor=M.+Brileyauthor=A.+Stengerauthor=F.+Fauranauthor=J.+P.+Couzinier&title=1-Aryl-2-%28aminomethyl%29cyclopropanecarboxylic+acid+derivatives.+A+new+series+of+potential+antidepressants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm00385a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00385a013%26sid%3Dliteratum%253Aachs%26aulast%3DBonnaud%26aufirst%3DB.%26aulast%3DCousse%26aufirst%3DH.%26aulast%3DMouzin%26aufirst%3DG.%26aulast%3DBriley%26aufirst%3DM.%26aulast%3DStenger%26aufirst%3DA.%26aulast%3DFauran%26aufirst%3DF.%26aulast%3DCouzinier%26aufirst%3DJ.%2BP.%26atitle%3D1-Aryl-2-%2528aminomethyl%2529cyclopropanecarboxylic%2520acid%2520derivatives.%2520A%2520new%2520series%2520of%2520potential%2520antidepressants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D318%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesleh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span> </span><span class="NLM_article-title">Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1346</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1346-1349&author=C.+Chenauthor=B.+Dyckauthor=B.+A.+Fleckauthor=A.+C.+Fosterauthor=J.+Greyauthor=F.+Jovicauthor=M.+Meslehauthor=K.+Phanauthor=J.+Tamiyaauthor=T.+Vickersauthor=M.+Zhang&title=Studies+on+the+SAR+and+pharmacophore+of+milnacipran+derivatives+as+monoamine+transporter+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DGrey%26aufirst%3DJ.%26aulast%3DJovic%26aufirst%3DF.%26aulast%3DMesleh%26aufirst%3DM.%26aulast%3DPhan%26aufirst%3DK.%26aulast%3DTamiya%26aufirst%3DJ.%26aulast%3DVickers%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.%26atitle%3DStudies%2520on%2520the%2520SAR%2520and%2520pharmacophore%2520of%2520milnacipran%2520derivatives%2520as%2520monoamine%2520transporter%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1346%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Vickers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jovic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3230</span><span class="NLM_x">–</span> <span class="NLM_lpage">3235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3230-3235&author=T.+Vickersauthor=B.+Dyckauthor=J.+Tamiyaauthor=M.+Zhangauthor=F.+Jovicauthor=J.+Greyauthor=B.+A.+Fleckauthor=A.+Aparicioauthor=M.+Johnsauthor=L.+Jinauthor=H.+Tangauthor=A.+C.+Fosterauthor=C.+Chen&title=Studies+on+a+series+of+milnacipran+analogs+containing+a+heteroaromatic+group+as+potent+norepinephrine+and+serotonin+transporter+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVickers%26aufirst%3DT.%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DTamiya%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJovic%26aufirst%3DF.%26aulast%3DGrey%26aufirst%3DJ.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26aulast%3DAparicio%26aufirst%3DA.%26aulast%3DJohns%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DH.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520milnacipran%2520analogs%2520containing%2520a%2520heteroaromatic%2520group%2520as%2520potent%2520norepinephrine%2520and%2520serotonin%2520transporter%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3230%26epage%3D3235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Shuto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujita, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, A.</span><span> </span><span class="NLM_article-title">(+/−)-(<i>Z</i>)-2-(Aminomethyl)-1-phenylcyclopropanecarboxamide derivatives as a new prototype of NMDA receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2964</span><span class="NLM_x">–</span> <span class="NLM_lpage">2968</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00015a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=2964-2968&author=S.+Shutoauthor=H.+Takadaauthor=D.+Mochizukiauthor=R.+Tsujitaauthor=Y.+Haseauthor=S.+Onoauthor=N.+Shibuyaauthor=A.+Matsuda&title=%28%2B%2F%E2%88%92%29-%28Z%29-2-%28Aminomethyl%29-1-phenylcyclopropanecarboxamide+derivatives+as+a+new+prototype+of+NMDA+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00015a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00015a019%26sid%3Dliteratum%253Aachs%26aulast%3DShuto%26aufirst%3DS.%26aulast%3DTakada%26aufirst%3DH.%26aulast%3DMochizuki%26aufirst%3DD.%26aulast%3DTsujita%26aufirst%3DR.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DOno%26aufirst%3DS.%26aulast%3DShibuya%26aufirst%3DN.%26aulast%3DMatsuda%26aufirst%3DA.%26atitle%3D%2528%252B%252F%25E2%2588%2592%2529-%2528Z%2529-2-%2528Aminomethyl%2529-1-phenylcyclopropanecarboxamide%2520derivatives%2520as%2520a%2520new%2520prototype%2520of%2520NMDA%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D2964%26epage%3D2968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><div class="note"><p class="first last">Also, see the following:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Also%2C+see+the+following%3A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_contrib-group">Xu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karady, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschaen, D.</span><span> </span><span class="NLM_article-title">Stereocontrolled synthesis of trisubstituted cyclopropanes: expedient, atom-economical, asymmetric syntheses of (+)-Bicifadine and DOV21947</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3885</span><span class="NLM_x">–</span> <span class="NLM_lpage">3888</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol061650w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=3885-3888&author=F.+Xuauthor=J.+A.+Murryauthor=B.+Simmonsauthor=E.+Corleyauthor=K.+Fitchauthor=S.+Karadyauthor=D.+Tschaen&title=Stereocontrolled+synthesis+of+trisubstituted+cyclopropanes%3A+expedient%2C+atom-economical%2C+asymmetric+syntheses+of+%28%2B%29-Bicifadine+and+DOV21947"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fol061650w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol061650w%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DF.%26aulast%3DMurry%26aufirst%3DJ.%2BA.%26aulast%3DSimmons%26aufirst%3DB.%26aulast%3DCorley%26aufirst%3DE.%26aulast%3DFitch%26aufirst%3DK.%26aulast%3DKarady%26aufirst%3DS.%26aulast%3DTschaen%26aufirst%3DD.%26atitle%3DStereocontrolled%2520synthesis%2520of%2520trisubstituted%2520cyclopropanes%253A%2520expedient%252C%2520atom-economical%252C%2520asymmetric%2520syntheses%2520of%2520%2528%252B%2529-Bicifadine%2520and%2520DOV21947%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D3885%26epage%3D3888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Owens, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plott, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=9400006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK1cXis1GmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=1305-1322&author=M.+J.+Owensauthor=W.+N.+Morganauthor=S.+J.+Plottauthor=C.+B.+Nemeroff&title=Neurotransmitter+receptor+and+transporter+binding+profile+of+antidepressants+and+their+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites</span></div><div class="casAuthors">Owens, Michael J.; Morgan, W. Neal; Plott, Susan J.; Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1305-1322</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Several new antidepressants that inhibit the serotonin (SERT) and norepinephrine transporters (NET) have been introduced into clin. practice the past several years.  This report focuses on the further pharmacol. characterization of nefazodone and its metabolites within the serotonergic and noradrenergic systems, in comparison with other antidepressants.  By use of radioligand binding assays, we measured the affinity (Ki) of 13 antidepressants and 6 metabolites for the rat and human SERT and NET.  The Ki values for eight of the antidepressants and three metabolites were also detd. for the rat 5-HT1A, 5-HT2A and muscarinic cholinergic receptors, the guinea pig histamine1 receptor and the human alpha-1 and alpha-2 receptors.  These data are useful for predicting side effect profiles and the potential for pharmacodynamic drug-drug interactions of antidepressants.  Of particular interest were the findings that paroxetine, generally thought of as a selective SERT antagonist, possesses moderately high affinity for the NET and that venlafaxine, which has been described as a "dual uptake inhibitor", possesses weak affinity for the NET.  We obsd. significant correlations in SERT (r = 0.965) or NET (r = 0.983) affinity between rat and human transporters.  Significant correlations were also obsd. between muscarinic cholinergic and NET affinity.  There are several significant correlations between affinities for the 5-HT1A, 5-HT2A, histamine1, alpha-1 and alpha-2 receptors.  These novel findings, not widely described previously, suggest that many of the, individual drugs studied in these expts. possess some structural characteristic that dets. affinity for several G protein-coupled, but not muscarinic, receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradn8u7KxbQrVg90H21EOLACvtfcHk0liVVCUW65IhCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis1GmtQ%253D%253D&md5=fa8d12aed5de3875493c77cd9a869933</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DM.%2BJ.%26aulast%3DMorgan%26aufirst%3DW.%2BN.%26aulast%3DPlott%26aufirst%3DS.%2BJ.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DNeurotransmitter%2520receptor%2520and%2520transporter%2520binding%2520profile%2520of%2520antidepressants%2520and%2520their%2520metabolites%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D1305%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinçon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouretti, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of milnacipran in liver impairment</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVeisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=273-279&author=C.+Puozzoauthor=H.+Albinauthor=G.+Vin%C3%A7onauthor=D.+Deprezauthor=J.+M.+Raymondauthor=M.+Amouretti&title=Pharmacokinetics+of+milnacipran+in+liver+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of milnacipran in liver impairment</span></div><div class="casAuthors">Puozzo, C.; Albin, H.; Vincon, G.; Deprez, D.; Raymond, J. M.; Amouretti, M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">273-279</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Medecine et Hygiene</span>)
        </div><div class="casAbstract">The pharmacokinetics of single 50 mg oral and i.v. doses of milnacipran, a new non-tricyclic antidepressant drug, were compared in 11 chronic liver impaired (LI) subjects and in 6 control subjects.  Hepatic impairments, classified according to the PUGH scale were moderate (1 grade A), intermediate (6 grade B) and severe (4 grade C).  Concns. of unchanged drug and its conjugated form (its main metabolite) were measured in plasma and urines.  In control subjects, milnacipran present high abs. bioavailability (mean value of 90%).  Around 50% of the dose are excreted in urines as unchanged, while ≈14% are excreted as glucuroconjugate.  The remaining is composed of free and conjugated phase I inactive metabolites.  Administration of milnacipran in LI subjects results in non-significant changes in its pharmacokinetics, although its variability is increased.  Unchanged drug exposure is not modified in LI subjects, while plasma levels of the conjugate are slightly decreased compared to the control group.  This could either be due to a slight redn. in the conjugation process, or to a change in the distribution of the drug as urine excretion of both unchanged and conjugated forms are not modified compared to the control group.  A few LI subjects present supra-bioavailability resulting in higher drug exposure after oral administration than after i.v. infusion.  These modifications are not clin. relevant as drug exposure of the parent drug is not modified.  As the unchanged drug is the only compd. responsible for the activity of milnacipran, no dosage adjustment is needed in patients presenting liver impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcrlLSav0IYbVg90H21EOLACvtfcHk0lg5VoitIDHzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVeisbk%253D&md5=79ffb2eb99672b7e060e9c9a5b6a78da</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DAlbin%26aufirst%3DH.%26aulast%3DVin%25C3%25A7on%26aufirst%3DG.%26aulast%3DDeprez%26aufirst%3DD.%26aulast%3DRaymond%26aufirst%3DJ.%2BM.%26aulast%3DAmouretti%26aufirst%3DM.%26atitle%3DPharmacokinetics%2520of%2520milnacipran%2520in%2520liver%2520impairment%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1998%26volume%3D23%26spage%3D273%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Puozzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozet, N</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baille, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ung, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zech, P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of milnacipran in renal impairment</span> <span class="citation_source-journal">Eur. J. Drug Metab. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVeisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1998&pages=280-286&author=C.+Puozzoauthor=N+Pozetauthor=D.+Deprezauthor=P.+Bailleauthor=H.+L.+Ungauthor=P.+Zech&title=Pharmacokinetics+of+milnacipran+in+renal+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of milnacipran in renal impairment</span></div><div class="casAuthors">Puozzo, C.; Pozet, N.; Deprez, D.; Baille, P.; Ung, H. L.; Zech, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">280-286</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Medecine et Hygiene</span>)
        </div><div class="casAbstract">The pharmacokinetics of a single 50 mg dose of milnacipran, a new non-tricyclic antidepressant drug, were compared in 8 chronic renal failure subjects (Clcreat between 9-84.5 mL min-1) and in 6 healthy volunteers.  Concns. of unchanged (F2207 racemate and F2695 and F2696, enantiomers) and glucuroconjugated drug (main metabolite) were measured using HPLC and GC-MS.  As for drugs mainly eliminated via renal route, the pharmacokinetics of milnacipran were markedly affected by impaired renal function with the elimination half-life of severely impaired subject being ≈3 times that of the control group.  Milnacipran apparent total clearance and renal clearance were pos. correlated with glomerular filtration rate, while non-renal clearance and apparent vol. of distribution were unaffected by renal impairment.  Plasma concns. of the glucuroconjugate were gradually increased in plasma, while its total urine excretion remained unchanged.  As for the racemate, pharmacokinetics of each enantiomer were modified by renal failure, although, as predictable from its higher renal clearance value, it was more marked for F2696 than for F2695.  Considering that modifications were shown to be proportional to the degree of renal impairment and that milnacipran presents low variability, the necessary dose adjustment is therefore easy to predict.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb9PemW1HhirVg90H21EOLACvtfcHk0lg5VoitIDHzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVeisbY%253D&md5=18a20c7d56f5fb53b657774929f1aa7e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPuozzo%26aufirst%3DC.%26aulast%3DPozet%26aufirst%3DN%26aulast%3DDeprez%26aufirst%3DD.%26aulast%3DBaille%26aufirst%3DP.%26aulast%3DUng%26aufirst%3DH.%2BL.%26aulast%3DZech%26aufirst%3DP.%26atitle%3DPharmacokinetics%2520of%2520milnacipran%2520in%2520renal%2520impairment%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D1998%26volume%3D23%26spage%3D280%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0lg5VoitIDHzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mattiuz, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponsler, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbuch, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shugert, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrad, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J. M.</span><span> </span><span class="NLM_article-title">Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1124%2Fdmd.31.1.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=12485957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtV2mtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=88-97&author=E.+L.+Mattiuzauthor=G.+D.+Ponslerauthor=R.+J.+Barbuchauthor=P.+G.+Woodauthor=J.+H.+Mullenauthor=R.+L.+Shugertauthor=Q.+Liauthor=W.+J.+Wheelerauthor=F.+Kuoauthor=P.+C.+Conradauthor=J.+M.+Sauer&title=Disposition+and+metabolic+fate+of+atomoxetine+hydrochloride%3A+pharmacokinetics%2C+metabolism%2C+and+excretion+in+the+Fischer+344+rat+and+beagle+dog"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog</span></div><div class="casAuthors">Mattiuz, Edward L.; Ponsler, G. Douglas; Barbuch, Robert J.; Wood, Paul G.; Mullen, John H.; Shugert, Richard L.; Li, Qimin; Wheeler, William J.; Kuo, Fengjiun; Conrad, Preston C.; Sauer, John-Michael</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-97</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">These studies were designed to characterize the disposition and metab. of atomoxetine hydrochloride [(-)-N-methyl-γ-(2-methylphenoxy)benzenepropanamine hydrochloride; formerly know as tomoxetine hydrochloride] in Fischer 344 rats and beagle dogs.  Atomoxetine was well absorbed from the gastrointestinal tract and cleared primarily by metab. with the majority of its metabolites being excreted into the urine, 66% of the total dose in the rat and 48% in the dog.  Fecal excretion, 32% of the total dose in the rat and 42% in the dog, appears to be due to biliary elimination and not due to unabsorbed dose.  Nearly the entire dose was excreted within 24 h in both species.  In the rat, low oral bioavailability was obsd. (F = 4%) compared with the high oral bioavailability in dog (F = 74%).  These differences appear to be almost purely mediated by the efficient first-pass hepatic clearance of atomoxetine in rat.  The biotransformation of atomoxetine was similar in the rat and dog, undergoing arom. ring hydroxylation, benzylic oxidn. (rat only), and N-demethylation.  The primary oxidative metabolite of atomoxetine was 4-hydroxyatomoxetine, which was subsequently conjugated forming O-glucuronide and O-sulfate (dog only) metabolites.  Although subtle differences were obsd. in the excretion and biotransformation of atomoxetine in rats and dogs, the primary difference obsd. between these species was the extent of first-pass metab. and the degree of systemic exposure to atomoxetine and its metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJhLRs_9WiNLVg90H21EOLACvtfcHk0lg5VoitIDHzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtV2mtA%253D%253D&md5=dab2a419ce1b74460be217a3ee195c64</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fdmd.31.1.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.31.1.88%26sid%3Dliteratum%253Aachs%26aulast%3DMattiuz%26aufirst%3DE.%2BL.%26aulast%3DPonsler%26aufirst%3DG.%2BD.%26aulast%3DBarbuch%26aufirst%3DR.%2BJ.%26aulast%3DWood%26aufirst%3DP.%2BG.%26aulast%3DMullen%26aufirst%3DJ.%2BH.%26aulast%3DShugert%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DKuo%26aufirst%3DF.%26aulast%3DConrad%26aufirst%3DP.%2BC.%26aulast%3DSauer%26aufirst%3DJ.%2BM.%26atitle%3DDisposition%2520and%2520metabolic%2520fate%2520of%2520atomoxetine%2520hydrochloride%253A%2520pharmacokinetics%252C%2520metabolism%252C%2520and%2520excretion%2520in%2520the%2520Fischer%2520344%2520rat%2520and%2520beagle%2520dog%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Descending control of pain</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1016%2FS0301-0082%2802%2900009-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=12034378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2002&pages=355-474&author=M.+J.+Millan&title=Descending+control+of+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Descending control of pain</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">355-474</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Upon receipt in the dorsal horn (DH) of the spinal cord, nociceptive (pain-signalling) information from the viscera, skin and other organs is subject to extensive processing by a diversity of mechanisms, certain of which enhance, and certain of which inhibit, its transfer to higher centers.  In this regard, a network of descending pathways projecting from cerebral structures to the DH plays a complex and crucial role.  Specific centrifugal pathways either suppress (descending inhibition) or potentiate (descending facilitation) passage of nociceptive messages to the brain.  Engagement of descending inhibition by the opioid analgesic, morphine, fulfils an important role in its pain-relieving properties, while induction of analgesia by the adrenergic agonist, clonidine, reflects actions at α2-adrenoceptors (α2-ARs) in the DH normally recruited by descending pathways.  However, opioids and adrenergic agents exploit but a tiny fraction of the vast panoply of mechanisms now known to be involved in the induction and/or expression of descending controls.  For example, no drug interfering with descending facilitation is currently available for clin. use.  The present review focuses on: (1) the organization of descending pathways and their pathophysiol. significance; (2) the role of individual transmitters and specific receptor types in the modulation and expression of mechanisms of descending inhibition and facilitation and (3) the advantages and limitations of established and innovative analgesic strategies which act by manipulation of descending controls.  Knowledge of descending pathways has increased exponentially in recent years, so this is an opportune moment to survey their operation and therapeutic relevance to the improved management of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgzpGfk_Zv97Vg90H21EOLACvtfcHk0liXQQEdB7afIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktVarsr0%253D&md5=9826f6eb6f47fb3e9d663adf496f5456</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0301-0082%2802%2900009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0301-0082%252802%252900009-6%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDescending%2520control%2520of%2520pain%26jtitle%3DProg.%2520Neurobiol.%26date%3D2002%26volume%3D66%26spage%3D355%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubner, R.</span><span> </span><span class="NLM_article-title">Descending modulation in persistent pain: an update</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=1-6&author=K.+Renauthor=R.+Dubner&title=Descending+modulation+in+persistent+pain%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DK.%26aulast%3DDubner%26aufirst%3DR.%26atitle%3DDescending%2520modulation%2520in%2520persistent%2520pain%253A%2520an%2520update%26jtitle%3DPain%26date%3D2002%26volume%3D100%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rygh, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickenson, A. H.</span><span> </span><span class="NLM_article-title">Bad news from the brain: descending 5-HT pathways that control spinal pain processing</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=613-617&author=R.+Suzukiauthor=L.+J.+Ryghauthor=A.+H.+Dickenson&title=Bad+news+from+the+brain%3A+descending+5-HT+pathways+that+control+spinal+pain+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DRygh%26aufirst%3DL.%2BJ.%26aulast%3DDickenson%26aufirst%3DA.%2BH.%26atitle%3DBad%2520news%2520from%2520the%2520brain%253A%2520descending%25205-HT%2520pathways%2520that%2520control%2520spinal%2520pain%2520processing%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D613%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhart, G. F.</span><span> </span><span class="NLM_article-title">Spinal serotonin receptors mediate descending facilitation of a nociceptiive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">550</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1016%2F0006-8993%2891%2990402-H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=1888999" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=1991&pages=35-48&author=M.+Zhouauthor=G.+F.+Gebhart&title=Spinal+serotonin+receptors+mediate+descending+facilitation+of+a+nociceptiive+reflex+from+the+nuclei+reticularis+gigantocellularis+and+gigantocellularis+pars+alpha+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990402-H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990402-H%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DGebhart%26aufirst%3DG.%2BF.%26atitle%3DSpinal%2520serotonin%2520receptors%2520mediate%2520descending%2520facilitation%2520of%2520a%2520nociceptiive%2520reflex%2520from%2520the%2520nuclei%2520reticularis%2520gigantocellularis%2520and%2520gigantocellularis%2520pars%2520alpha%2520in%2520the%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D550%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Yaksh, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCumber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathbun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkmus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaksh, M. C.</span><span> </span><span class="NLM_article-title">An automated flinch detecting system for use in the formalin nociceptive bioassay</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2386</span><span class="NLM_x">–</span> <span class="NLM_lpage">2402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2001&pages=2386-2402&author=T.+L.+Yakshauthor=G.+Ozakiauthor=D.+McCumberauthor=M.+Rathbunauthor=C.+Svenssonauthor=S.+Malkmusauthor=M.+C.+Yaksh&title=An+automated+flinch+detecting+system+for+use+in+the+formalin+nociceptive+bioassay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYaksh%26aufirst%3DT.%2BL.%26aulast%3DOzaki%26aufirst%3DG.%26aulast%3DMcCumber%26aufirst%3DD.%26aulast%3DRathbun%26aufirst%3DM.%26aulast%3DSvensson%26aufirst%3DC.%26aulast%3DMalkmus%26aufirst%3DS.%26aulast%3DYaksh%26aufirst%3DM.%2BC.%26atitle%3DAn%2520automated%2520flinch%2520detecting%2520system%2520for%2520use%2520in%2520the%2520formalin%2520nociceptive%2520bioassay%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D2001%26volume%3D90%26spage%3D2386%26epage%3D2402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J. M.</span><span> </span><span class="NLM_article-title">An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm8009537&amp;key=10.1016%2F0304-3959%2892%2990041-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8009537&amp;key=1333581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A280%3ADyaK3s%252FoslShtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1992&pages=355-363&author=S.+H.+Kimauthor=J.+M.+Chung&title=An+experimental+model+for+peripheral+neuropathy+produced+by+segmental+spinal+nerve+ligation+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat</span></div><div class="casAuthors">Kim S H; Chung J M</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-63</span>
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    </div><div class="casAbstract">We attempted to develop an experimental animal model for peripheral neuropathic pain.  Under sodium pentobarbital anesthesia, both the L5 and L6 spinal nerves (group 1) or the L5 spinal nerve alone (group 2) of one side of the rat were tightly ligated.  For comparison, a parallel study was conducted with another group of rats (group 3) which received a partial tight sciatic nerve ligation, a paradigm developed previously as a neuropathy model.  Withdrawal latencies to application of radiant heat to the foot were tested for the next 16 weeks in all 3 groups.  Sensitivity of the hind paw to mechanical stimulation was tested with von Frey filaments.  The general behavior of each rat was noted during the entire test period.  Results suggested that the surgical procedure in all 3 groups produced a long-lasting hyperalgesia to noxious heat (at least 5 weeks) and mechanical allodynia (at least 10 weeks) of the affected foot.  In addition, there were behavioral signs of the presence of spontaneous pain in the affected foot.  Therefore, we believe we have developed an experimental animal model for peripheral neuropathy using tight ligations of spinal nerves.  The model manifests the symptoms of human patients with causalgia and is compatible with a previously developed neuropathy model.  The present model has two unique features.  First, the surgical procedure is stereotyped.  Second, the levels of injured and intact spinal segments are completely separated, allowing independent experimental manipulations of the injured and intact spinal segments in future experiments to answer questions regarding mechanisms underlying causalgia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEPstJUQcfvtj_Vg2vObihfW6udTcc2eYCvjozfkdwqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FoslShtw%253D%253D&md5=13917a9997b26f37cd039fa54ee7eb36</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2F0304-3959%2892%2990041-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3959%252892%252990041-9%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DChung%26aufirst%3DJ.%2BM.%26atitle%3DAn%2520experimental%2520model%2520for%2520peripheral%2520neuropathy%2520produced%2520by%2520segmental%2520spinal%2520nerve%2520ligation%2520in%2520the%2520rat%26jtitle%3DPain%26date%3D1992%26volume%3D50%26spage%3D355%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Koch, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faurot, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuirk, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span> </span><span class="NLM_article-title">Modulation of mechano-hyperalgesia by clinically effective analgesics in rats with a peripheral mononeuropathy</span> <span class="citation_source-journal">Analgesia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm8009537&amp;key=1%3ACAS%3A528%3ADyaK28XlvFyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=157-164&author=B.+D.+Kochauthor=G.+F.+Faurotauthor=J.+R.+McGuirkauthor=D.+E.+Clarkeauthor=J.+C.+Hunter&title=Modulation+of+mechano-hyperalgesia+by+clinically+effective+analgesics+in+rats+with+a+peripheral+mononeuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of mechano-hyperalgesia by clinically effective analgesics in rats with a peripheral mononeuropathy</span></div><div class="casAuthors">Koch, Bruce D.; Faurot, George F.; McGuirk, Jennifer R.; Clarke, David E.; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Analgesia (Elmsford, New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">AALGEB</span>;
        ISSN:<span class="NLM_cas:issn">1071-569X</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">An important feature of pain syndromes assocd. with an injured peripheral nerve is excessive sensitivity to previously innocuous and noxious mech. stimuli.  Whereas the former (mech. allodynia) has been studied extensively in exptl. models of neuropathic pain, extremely limited data have been produced concerning the latter (mech. hyperalgesia).  This is due, in part, to the variability and imprecise nature of the traditional methods used to measure mech. hyperalgesia.  Recently, a more robust and reliable method for measuring mech. hyperalgesia has been described: the Tal and Bennett pin prick assay.  We have investigated the ability of this assay to predict clin. effectiveness by using three categories of drugs favored for the treatment of neuropathic pain.  The tricyclic antidepressants, amitriptyline and desipramine, and the local anesthetic mexiletine all produced dose-dependent antihyperalgesia, as did the μ-opiate, morphine.  In contrast, the nontricyclic antidepressant fluoxetine was ineffective at doses well above those reported to block the neuronal uptake of serotonin, a finding consistent with available clin. data.  Carbamazepine was active only at doses above those that are anticonvulsant.  In conclusion, the pin prick test is a robust and reproducible assay for exptl. mech. hyperalgesia and may be useful to predict the clin. efficacy of drugs intended for the treatment of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYF8_LH9nA67Vg90H21EOLACvtfcHk0lhU94dQIIfduw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFyhtLo%253D&md5=7f9d0e514c8d7ee9942bdc12f531d8c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DB.%2BD.%26aulast%3DFaurot%26aufirst%3DG.%2BF.%26aulast%3DMcGuirk%26aufirst%3DJ.%2BR.%26aulast%3DClarke%26aufirst%3DD.%2BE.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DModulation%2520of%2520mechano-hyperalgesia%2520by%2520clinically%2520effective%2520analgesics%2520in%2520rats%2520with%2520a%2520peripheral%2520mononeuropathy%26jtitle%3DAnalgesia%26date%3D1996%26volume%3D2%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/jm8009537">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83770"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis data of final compounds and HPLC chromatograms of <b>5g</b> and <b>5h</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8009537/suppl_file/jm8009537_si_001.pdf">jm8009537_si_001.pdf (667.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8009537&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm8009537%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8009537" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                237KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679928f4ddf424ad","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
